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Domiatlfk lierpeHformîs I# q comparatively uncommon âûn disease 
cliaraaferî$ecî by ahronfc relapsing lesions affecting predominantly i’he elbows# 
knees  ^ -shoulders^  buttocks areoond scalp# As Indicated by the nome^  the 
hall mark:of the disease Is the,^ appearance of grouped vesicles on'On 
erythematous base# as occurs In herpes simplex or herpes zoster; but 
commonly various other primary and secondary lesions occur  ^ and these may 
moke the diagnosis less obviousè The eruption Is normally accompanied by 
severe Itching, but fortunately ct good response Is usually obtained wîtîi the 
empirical use of the drugs dopsone or sulphopyrldln©# The doSe of dopsone, 
the drug most commonly used^  necessary to control dermatitis herpetiformis 
Is very variable^ and It was this fact which prompted the Initiation of this 
Investigation* the hypothesis being tested was that dopsono Induced o 
malabsorption state with consequent variable absorption of the drug#
Several months after the study began, Marks, Shuster and Watson (1966) 
reported. In a preliminary communication, the finding of I -Intestinal 
abnormalities In dermatitis herpetiformis; and these changes were present 
In some patients wlio had never received specific drug therapy for foelr 
disease. The Initial findings In the present study were similar fo those of 
Marks and her colleagues (Fraser ©t g l#, 1967), and so, the Investigation 
Was/
was contînyad over a five yect period to delineate further the enteropathy 
of dermatitis herpetîfonnîSf Also, the report by Fry et ol » (1967) , on 
study of 0 small group of patients with dermatitis herpetiformis, of the 
OGcurrence of an incidence of serum IgM deficiency similar to that Of 
coeilac disease, prompted the Study of serum Immunoglobulin levels In a 
larger group of dermatitis herpetiformis patients to try to determine whether 
a relationship existed between these levels and the presence of disease In 
the dcin or the small-Intestine . In addition to the findings Of Fry et ol # 
(1967) on serum Immunoglobulin#, the reports of Immunoglobulins In the 
skin (Cormane, 1967; Van der Meer, 1969; Cormane et gl , ,  1970) and 
the demonstration of gluten sensitivity In the small-Intestine (Shuster et a l., 
1968) suggested that the occasional occurrence of putative autoimmune 
disease In patients with dermatitis herpetiformis might not be coincidental 
but part of the spectrum of Immunological abnormalities present In this 
disease* the incidence of serum outoantlbodles was determined to Investigate 
this possibility.
The study, therefore, was carried out In three ports. In the first, the 
structure and function of the small intestine In dermatitis herpetiformis was 
determined with particular reference to the use of the small-Intestinal biopsy 
capsule. In addition to histological assessment of the mucosa, dîsàccharîdase 
enzyme concentrations were assayed In some specimens, and the effect of 
the/
the mucosal abnormdlîtîes on the patient was învestîgctted#
Serum Immunoglobulins were assayed In the second port of the study, 
and evidence to substantiate a specific relationship between Immunoglobulin 
levels and the skin eruption was sought by measuring serum Immunoglobulin 
and complement (C*3) levels ot different phases of disease activity # Patterns 
of serum Immunoglobulin levels In various skin diseases, not associated with 
definite smell intestinal abnormalities, were also ascertained, to exclude a 
non-specific effect of skin diSec# on serum Immunoglobulins,
In the third part of the study, the Incidence of anti-thyroid; dntl**gastrlc 
and anti-nuclear antibodies was determined In a group of patients with 
dermatitis herpetiformis, and In 0 control group matched for age odd sex.
Further Interpretation of the results obtained was sought by relating Serum 
autpontlbodles to the small-întostînal biopsy grading (determined In Port I) 
and serum Immunoglobulin levels (determined In Part II).
The results obtained in this study were of some Immediate Interest and 
significance during the period when the Investigation was being carried out, 
and So part of the material forming the thesis has already been published.
The papers containing this material are as follows:-
Fraser, N .G # (1970) Autoantîbèdîes in Dermatitis Herpetiformis, Br* J. Derm., 
88, 609.
Fraser,/
4Fraser# N#G.# Beck# J#S, â Aîbert-Recht# F, (197Î) Serum Complément (C*8) 
mû Immunoglobulin Levels in Dermatitis Herpetîformîs-. Br# j*  Dorm.#
85# 314#
Froaor# N.G$# Dick# Heather M# & Crichton# W.B. (1969) ImmuWglobullns In 
Dermatitis Herpetiformis and Various Other Skin Diseases. Br'i J. Dorm.# 
81# 89.
Fraser# N .G .# Ferguson# Anne & Murray# D. (1968) Dermatitis Fferpatfformls In 
Two Patients with Idiopathic Steatorrhoea (Adult Co©Hoc DlSOose), Br.
mod. J # 4 # 30 $
Fraser# N#G.# Murray# D. & Alexander# J .O 'D . (1967) Structure and Function 
of the Small Intestine In Dermatitis Herpetiformis. Br. j .  Dorm.# 79# 509. 
MoNekh# A.S.# Fraser# N.G# & Morley, W.N. (1970) Dermatitis
Herpetiformis In a Treated Coeilac Child, Archs Dis, Chlldh## 45# 279. 
Final ly# as the concept of dermatitis herpetiformis has been modified since 
the first description by Duhring In 1884# It was necessary first# before 
presenting the three ports of the Investigation# to discuss the modern concept 
of this disease and the criteria used In diagnosis.
DIAGNOSIS OF DERMATITIS HERPETIFORMIS
Hktorlcial Concept 
In 1884# Duhrang described a number of different elinicol manifestations 
affecting the skin which he bçlièyed were due to the same basic morbid 
process. The different clinical types were categorized according to the 
predominant primary lesion -  erythematous# papular# vesicular# bullous# 
pustular; the title multiform was given to the type In which no particular 
lesion predominated. The belief that all these forms represented the Same 
disease proqe^ was based on the observation that changes from one type to 
another could occur at different times In the same patient* The disease was 
designated dermatitis herpetiformis: the term herpetiformis being used because 
of the tendency of the primary lestons to occur in groups# a feature noted by 
Duhring in all his cases. Other characteristics emphasized by Duhring were 
that the disease was usually chronic# with a “disposition to appear In 
repeated successive outbreaks'*; was marked by sever© itching; and was 
“©xceodingly rebellious to treatment”. Four years later# Brocq# in agreeing 
with the above concept# emphasized the polymorphous nature of the eruption 
and the outstanding symptomatic feature# intense itching or pain# In the 
title "dermatitis polymorph© douloureuse". However# although the 
concept of dermatitis herpetiformis is normally attributed to Duhring and 
Brocq#/
Bmuq# Tilbury Fox hod clearly described this entity In 1880 In the paper "A 
Clinical Study on Hydroa” published posthumously by his brother Colcott Fox.
The original concept of dermatitis herpetiformis# however# was wide, 
Including such diseases as Impetigo herpetiformis (Hebra# 1872) and herpes 
gestationiS (Bulkley# 1873)# and diseases more recently delineated -  
pemphigoid (Lover# 1953)# subcorneal pustular dermatosis (Sneddon and 
Wilkinson# 1956) and {uvenllo pemphigoid (Kim and WInkelmann# 1961). 
These diseases are now regarded at least for purposes of definition# os 
separate diseases# although exact classification awaits further Information. 
The historical concept# therefore# having been modified# It seems likely 
that dermatitis herpetiformis# as It is now understood# Is a single disease 
entity# a conclusion accepted by Tolman et a l. (1959) in their discursive 
paper on this subject.
Criteria for Diagnosis
Nowadays# several criteria are used in the diagnosis of dermatitis 
herpetiformis and these will be considered in turn.
Clinical features -  The disease may start as a localised eruption# e .g . on 
the elbov/s# which after a period of months or years becomes widespread# or# 
it may be generalised from the beginning. In relation to the primary lesions# 
reference may still be made fo the careful description of Duhring. Th© 
vesicular/
vesicular variety is the most common# the vesicles being of different Sizes 
varying from o pin-head to a pea. These are firm, tensely distended# arising 
usually from normal coloured skin When single but with a marked tendency to 
aggregate In Small clusters upon 0 slightly raised erythematous base (thus the 
resemblance to herpetic infections) (Fig* 1# 2)* Less common iS the 
erythematous variety in which erythematous patches occur which if oedematous 
resemble urticaria and if confluent show mqrglnate outlines (Fig* 3). Maculo- 
papules and vesico-papules may also be seen in this form making th^ true 
diagnosis mpre obvious. Duhring*S pustular form of dermatitis herpetiformis 
is less clearly defined than the previous two forms as the pustules ore commonly 
intermingled with vesicles and bullae. A pustular form may# however# 
precede or appear at intervals during the course of the more common vesicular 
variety. The popular variety Is probably less uncommon than Duhring 
suggested (Bolgert and Chastanet# 1963) and is characterised by groups of 
small or large pea-sized papules generally excoriated from scratching.
Bullae (i*e . blistering lesions ^ l  cm diameter) are rare in dermatitis 
herpetiformis although they may be seen in the exacerbation following 
withdrawal of suppressive therapy (Rook et o l.# 1968). In some patients 
different primary lesions may occur without the predominance of any (the 
multiform variety of Duhring). Lesions of the oral mucosa are rare and 
transient/
8transient (Rook et al . # 1968)# and involvement of other mucous membranes 
has not been reported, Second<xy lesions# particularly excoriated primary 
lesions# 0#  common#; and occosfonOlly crusting and eczématisation may be 
seen.’ Healing of the lesions of dermatitis herpetiformis is often folfoV/ed 
by pigmenfotion and Scarring
The distribution of dermatitis herpetiformis Is highly characteristic there 
being a marked predilection for the extensor surfaces of the elbows and knees# 
shoulders# buttocks area and notol cleft and the scalp* Any part pf the 
integument may# however# be affected *
Slight constitutional sympfoms may precede or accompany an exacerbation 
of the disease# but the marked symptomatic feature of dermatitis herpetiformis 
is severe itching or burning* Rupture of vesicles by scratching commonly 
produces relief of itching.
As already stated# the course of the disease is chronic and variable with 
periods of spontaneous remission which may be complete and lost for years* 
More commonly# however# th# eruption does not completely disappear during 
these periods# and the disease persists for many years or indefinitely *
The age and sex of the patient ore of little help when considering the 
clinical diagnosis of dermotitk herpetiformis# although the diseme is uncommon 
below the oge of 5 years (Kim and WInkelmann# 1961) and over the age of 60 
years/
years (Smith# 1966); males or© affected about twice os often os females 
(Eyster and Klerland# 1951),
Skin biopsy -  Aggregation of neutrophils and eosinophils In the dermal 
papillae with associated oedema and later vesicle formation was first 
suggested t© be pathognomonic for dermatitis herpetiformis by Allen (1954). 
These papillary microabscesses con be seen in early lesions and lead to the 
formation of multiloculor bullae (Fig, 4)* In later lesions they can often 
be seen at the periphery of unilocular blisters. These views were endorsed 
by the studies of Pieford and Whîmster (1961) and MacVicar et ol . (1963). 
Other wthors# however# doubted the specificity of the papillary micro- 
abscesses and Indicated that these could also form at the periphery of bullae 
in pemphigoid (Bolgert and Chostanet# 1963; Jablondca and Chorzelskî# 1963; 
lever# 1965), Nevertheless# more recently Lever (1967) has stated that "the 
presence of an early multiloculor vesicle with microabscesses at the tip of 
each papilla can be regarded diagnostic for dermatitis herpetiformis"# 
these features being best seen in "an erythematous area without clinically 
visible vesicles". The biopsy# therefore# of on early lesion In dermatitis 
herpetiformis will confirm the diagnosis; but unfortunately these lesions are 
often quickly excoriated thus destroying the distinctive histological features* 
This difficulty con be overcome# however# by making use of the ability of 
iodides/
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Iodides te Induce an exaccrbotten of the skin eruption. This aid te diagnosis 
will now b© considered*
Potd#(um W ide provocation fost -  The sensitivity of patten# with dermatitis 
herpetiformis te iodides# whethor applied locally as a patch test Or token 
orally# has long been recogniW (Goldsmith# 1936)* Pelsher (1947a) studied 
the nature of the adherence of the epidermis te the dermis te help elucidate 
this iodide effect* He concluded that the property of the iodide oiiten te 
swell collagen and thus decrease the odhesion between the epIdeWs and the 
dermis could be responsible for the induction of blistering In dermatitis 
hérpetîformte by iodides* In O later paper Folsher (1947b) by applying 20% 
potassium tedlde in petrolatum tecally produced epidermal-dermo) separation 
in patients with dermatitis herpetiformis; unfortunately# he does not record 
a hlSteloglcal assessment of the one positive reaction obtained In 80 normal 
control $ub|ects* Alcon (1947)# however# questioned the Specificity of this 
test by demonstrating that positive patch test reactions occurred in about one 
third of patients with various dermatesos* Again# the possibility of these 
reactions being due te a prlm#y Irritant or sensitivity reaction te the Iodide 
was not excluded histebgically* Little information Is available on the use 
of on oral dose of potassium iodide te Induce an exacerbation of dermatitis 
herpetlfonnis/
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herpetiformis but Eyster and Kierlond (1951) reported the test positive In 78% 
of the group of dermatitis herpetifomils patients studied. In the same series 
the potassium Iodide patch test was positive in only 50% of patients* It 
would appear# therefore# that the oral test, as would be expected In view 
of the poor penetration of iodide  ^through Intact skin (Rothman  ^ 1954)# is 
more helpful in the diagnosis of dermatitis herpetiformis and does not present 
the same pmblems of local irritation or sensitivity, The test should pmbobly 
be used# however# to obtain a lesion Suitable for skin biopsy# thus avoiding 
the possibility of false positive reactions (Andrews# 1946; Urbach and Le 
Winn# 1946),
Potassium Iodide# administered Orally in o dose of 1 *5-2 g to adult patients 
suspected clinically of suffering from dermatitis herpetiformis# was used on a 
number of occasions when patients presented during a quiescent phase of the 
disease (Fig. 5)# so that a lesion suitable for biopsy could be obtained 
(Fig* 6)* The ability of oral K| to Induce an exacerbation of the rash of 
dermatitis herpetiformis was also utilised during the study of Immunoglobulin 
and complement levels at different phases of disease activity (Part II)* 
Therapeutic test with dopsone -  Experience In the treatment of dermatitis 
herpetiformis with dopsone, following the initial usage by Esteves and Brandao 
(1950) and Cornbleet (1951)# caused some authors to suggest that the drug 
could/
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could b© used as a tharopeutio test for the disease (Laptev and Smalov# 1958; 
Van Koto I# 1960; March and Sowlcky# 1962). Smith (1966)# In his paper 
"The Diagnosis of Dermatitis #rp^tlform(s"# sought to evaluate the position 
of dcpsone m  a therapeutic # #  for diagnosis of this disease. From his 
studies of patients with dermdtlMS herpetiformis attending St. Jphh% Hospital 
for Diseases of the Skin over a 10 year period# he suggested that mdny of the 
patients diagnosed clinically as dermatitis herpetiformis and not responding 
to dc^sono therapy were examples of other diseases. However# ho admitted 
that some patients unresponsive fo dopsone clearly did conform to the clinical 
picture of this disease* Conversely# some of the skin biopsies performed from 
the group of patients sold to respond to drpsone therapy showed the histological 
feotures of other diseases. Although Smith concluded that this test was 
vqlu<d)le Cïè on aid to diagnosis# the foliaotes which he noted limit Its 
reliability# ond so It wo$ not used In the present study.
Differential Diagnosis 
Undoubtedly# to the experienced observer the occurrence of herpetlform 
skin lesions In the classical dfetributfon of dermatitis herpetiformis mokes the 
diagnosis reasonably secure* No difficulty should be experienced In 
differentiating dermatitis herpetiformis from the blistering eruption of 
pregnancy# herpes gestotlonls# and only rarely will pemphigoid# occurring 
as/
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qs It does In the elderly and dsfoetated with large tense bullae which excite 
only mild Itching# cause difficulty In dlfferentlol diagnosis* Occasionally# 
however# ti#  non-specific eruption which commonly precedes the fell-blown 
clinical picture of pemphigoid may be confused with dermatitis herpetiformis 
(Sneddon and Church# 1955)# and the true diagnosis only becomes clear In 
retrospect. In juvenile pemphigoid the bullous nature of the eruption# the 
distribution ond the relative rèsence of pruritus distinguish It from dermatitis 
herpetiformis occurring In children (Kim and WInkelmann# 1961; Oonpule# 
1967; Grant# 1968), Also# although the above mentioned diseases are all 
characterised by subepldermat blister formation# as Indicated previously# the 
hlstploglcal changes In the s!dn In dermatitis herpetiformis are distinctive 
provided that an early lesion Is blopsled. Pemphigus and subcorneal pustular 
dermatosis# the other chronic blistering diseases normally considered In this 
context# siteuld not provide serious difficulty In differential diagnosis os# In 
addition to the clinical oppearonces# the histological features ore quite 
different from those In dermatitis herpetiformis*
Unfortunately# however# In Some patients with dermatitis herpetiformis 
frank blistering only occurs sporodlcoHy largely due to the excoriation of 
early lesions by the patient# In these non-bllstering phases of the disease 
diagnosis on cllnlcql grounds alone Is Indeed hazardous* Confusion with 
scabies#/
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scabîes# generalised pruritus (from any cause) with excoriation# neurodermatitis# 
popular "ide" eruptions (e.g . from stosis dermatitis)# chronic folliculitis or 
pityriasis lichenoides may occur. Less commonly there may bo confusion with 
urticaria In the erythematous variety of dermatitis herpetiformis# and when 
secondary oczematlsatlon Is prominent a diagnosis of one of the clinical 
varieties of dermatitis may be mistakenly mode# It Is In the non-blistering 
phases of dermatitis herpetiformis that the potassium Iodide provocation test Is 
particularly useful in establishing the diagnosis*
Summary
The diagnosis of dermatitis herpetiformis may be regarded as established 
when# In a patient suspected clinically of suffering from this disease# skin 
biopsy of an early lesion shows the features of multiloculor vesicles with 
papillary mlcroabscesses; the lesion erupting spontaneously or being Induced 
by oral potassium Iodide.
Fig. 1 . -  Grouping of vesicular 
lesions on the bock of a patient 
with dermatitis herpetiformis.
Fig. 2 . -  Detail of F ig . 1 .
Fig. 3 .  -  Erythematous variety of dermatitis her­
petiformis with eruption resembling u rt icar ia .
F ig . 4 .  -  Skin histology in dermatitis herpeti­
formis showing typical papillary  microabscesses 
with early subepidermal blister formation.
H . and E . x 100.
F ig . 5 .  -  Excoriât 
popular lesions or 
elbows and knees 
during a relativel 
quiescent phase o 
the disease proce
F ig . 6 . -  Blisterir 
induced by oral I
PART I
STRUCTURE FUNCTION OF THE SMALL-INTESTINE
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INTRODUCTION
Folbwfhg the Introduction of lulphone drugs In the trootntent of dermatitis 
herpetiformis by Esteves and Brohdoo (1950) and Cornbleet (1951)# it soon 
become apparent that the dose of the drug required to control the eruption 
varied widely from patient to patient (Krulzlnga and Hammlngo# 1953;
Gal nan# 1954; Alexander# 1955), At the time the work of this theSis began 
It hod recently been noted that the drugs trlporanol and neomycin could Induce 
a motabsorptfo*^  state (Jacobsoh ot al m I960; Hvldt and K|eldsén# 1963; 
McPherson and Summersktll, i960) and so a pilot study of the structure and 
function of th® small-Intestine In dermatitis herpetiformis was undertaken to 
evaluate the possibility of dopsone# the sulphon© normally used In treatment# 
Inducing malabsorption with consequent variability of absorption of the drug. 
Little evidence to suggest maldbterptlon was present In the literature although# 
even before the advent of dopsone therapy# patients with dermatitis 
herpetiformis were noted to be often poorly nourished and debilitated (Becker 
and Obermc^er# 1944), Smith (1966)# however# In his review of dermatitis 
herpetiformis# hod described two patients on dopsone therapy who hod on 
associated malabsorption syndrO# *
After the Investigation began# It quickly became evident that while 
obnOrmalltl# of the structure and function of the small-Intestine were Indeed 
present#/
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present# dopsone therapy alone could not be held responsible# as these 
abnormalities were noted In some patients before treatment. These Initial 
findings were In agreement with the preliminary communication of Marks# 
Shuster and Watson (1966) on this subject. Consequently# the first port of 
this study was concerned with delineating the Incidence# nature and effect 
of the enteropathy In patients with dermatitis herpetiformis*
PATIENTS AND METHODS
60 patients (males# 37; females# 23) with dermatitis herpetiformis were 
studied. All were adults apart from 2 boys of 8 years. The clinical diagnosis 
was confirmed by skin biopsy In 55 patients; the other 5 patients were seen 
during a quiescent phase of the disease and before the use of the potassium 
Iodide provocation test. These latter patients were not excluded from the 
study as the clinical features were otherwise typical of dermatitis herpetiformis.
42 patients were from the geographical area of the Western Regional 
Hospital Board and 18 from the area of the North-Eastern Regional Hospital 
Board. All patients were Investigated as In-patients In Glasgow and Aberdeen 
respectively.
27 of the 60 patients In the series were not on any specific drug therapy 
at the time of small-Intestinal Investigation# 5 were on sulphopyrldlne and the 
remainder# 28, on dopsone.
A clinical history with particular reference to gastro-Intestinal symptoms 
was/
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waè obfolned# A family history of skin or Intestinal disease was sought.
The heights and weights of patients were recorded.
GaSftotete^tlnol Investigations 
Small 4nteStloal biopsy -  Peroral biopsy of the small-Intestine was carried out 
with the Watson capsule (Fig# 7) (Crosby and Kugler# 1957)* The patient 
Swallowed the capsule In the evening and the following morning, provided the 
position was satisfactory on radiological examination (Fig* 8), the capsule 
mechanism was fired by firm suction on the free end of the tubing with a 10 ml 
gloss Syringe# and the tube withdrawn. In some Instances, further time was 
required for the progress of the capsule# and then the patient was positioned 
on the right side If the duodenum hod not been reached# and on the left side 
If the capsule was already beyond the first part of the duqdenum. Not all 
specimens# however# were obtained from the first 20 cm of the {e{unum# the 
area aimed for# 6 being token from the distal duodenum because of slow 
progress of the capsule. In a few patients the test had to be repeated due 
to premature firing or non-firing of the capsule or separation of the cap from 
the body of the capsule. Smol I-Intestinal biopsy was repeated In 3 patients#
2# 8 and 12 months respectively after Starting dopsone therapy, No serious 
complications of this InvestlgotlOn occurred during the survey. Two patients# 
however# were excluded from this part of the study because of failure to swallow 
the/
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f\w  çdpwle îr» one* ond failure of fho qapwle to enter the duodenum In the 
oHier* in 2 patients (no. 25 Ond 35) this Investigation was perfi^ rmed In 
medleol units before the development of dermatitis herpetiformis and* In 
view of the Institution of o glutOn-free diet# these results rather thdn those 
of subsequent biopsies are used for purposes of alosslflcation* Complete 
oliniqol history and findings in these 2 patifnts ore recorded in the Appendix.
The specimens obtained werè fmmedtotaly placed In 10% formalin solution 
for later examination under the diSSeotIng and conventional miqroscOpes except 
In thoSe patients In whom dlSocchartdase enzyme activity was to be measured.
In those patients* the specimens Obtolnad ware divided Into two p#ts# one 
pert being placed In the formalin Solution and other part îminedîatèly weighed 
on a mIcrotorsion balance and than homogenized in at least 1 ml Of Ice cold 
distilled water. If the piece of tissue weighed more than 10 mg tha volume 
was ad justed to give a tissue concentration of 10 mg/ml * Dîsacqharîdase 
activity (moltosa* lactose and spcrose) was assayed Immediately thereafter 
(DahlqviSt# 1964).
Xylose « t^olerance test The test was performed In 50 patients; o 25 g dose was 
given to 18 patients and a 5 g dose to 32. Patients over 60 years v/ere not 
tested as deterioration In renal function with age reduces xylose excretion 
(Kendall# 19yO). The patients fasted overnight and after the oral dose of xylose
19
the amount of the sugar excreted in the urine in the next five hours was 
measured (Roe and Rice# 194#, The lower limit of normal for urinary xylose 
excretion in five hours was taken oS 4*1 for a 25 g dose and 1 *2 for q 5 g dose* 
Faecal■^ fçit éxcretion Stools Were collected over a five day period on 27 
occasion^# and over a three dqy period on 8 occasions# with pdtleiits on a 
normal word diet* Faecal-fdt content was estimated by the method of Van 
de Komer et p i* (1949), An excretion of more than 5 g per day was considered 
abnormal*
Smal I -bowel barium meal « This Investigation was performed in 12 patients. 
Lactose tolerance test -  An oral dose of 50 g lactose was given to 8 patients 
after an overnight fast and total reducing substances were measured in blood 
samples obtained immediately before the lactose was given and at half-*hourly 
intervals thereafter for 2 hourS (McMichael et ol. # 1965). In one patient the 
dose of lactose administered waS 100 g. Normally# the concentration of 
reducing substances in the blood rises by more than 25 mg per 1W ml,
Haematologlcal Investigations 
Peripheral4>lood examination This consisted of haemoglobin concentration# 
packed cell volume# mean corpuscular haemoglobin concentration# white 
blood count and film, A reticulocyte count was performed on patients who 
were/
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were an dapson© therapy.
Bgne?mdrmw ex(mI -  ThiS was only performed In some patients with 
non-dopSOne Induced anaemia ^
Serum Iron (normal range 70 -  160 ug/100 ml) )
H H  i|t f  * 1 > I  r j  if i ^
Serum yttOfflln (normal range 1 6 0 8 0 0  uug/ml) ) These assays
Serum fo!dfo (normal range ^  4™ 18 mug/ml) )
were undertoken In only a few patients In whom anaemia was present,
51Clearance of Cr4abelled heat^^omaged red cells (Marsh et a l.# 1966) -  
This test of splenic function was performed In 1 patient In whom the presence 
of Howell•^4oHy bodies In the red cells suggested the existence of #lenlc 
atrophy,
biochemical Investigations 
Serumr-oalclum# serum alkaline phosphatase and serum proteins were 
estimated by standard procedures.
RESULTS 
Clinical Findings
A history of chronic diarrhoea which could not be related to causative 
factors other than the small-Intestine was obtained in 10 out of 56 patients.
In 3 of the 10 patients with diarrhoea the smal I-Intestinal mucosa was noimal, 
O ne/
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One patient (no. 35) had been diagnosed as coelioc disease of infancy 6 
years before the rash appeared# and another (no. 25) os odult coelioc disease 
2 years before die rash appeared p The onset of diarrhoea preceded tha rash 
in another 5 patients. In only the 2 patients previously diagnosed os coelioc 
disease was the diarrhoea sufficiently troublesome to necessitate treatment 
with a gluten-free diet.
Five of the 60 patients In the series presented Initiolly in departments 
other thon the Skin Department With features secondary to their enteropathy 
(Table 1).
In no instance was a family history of dermatitis herpetiformis obtained# 
but 0 brother of one patient (no, 32) appears to have had childhood coelioc 
disease# and a brother of another patient (no, 58) hod recently been diagnosed 
as having odult coelioc disease.
Weight and Height -  The weight and height of each patient was recorded 
and deviation from average weight was obtained by reference to standard 
tables (Society of Actuaries# 1959). Patients with associated diseases liable 
to affect weight were excluded. Comparison was mode between the results 
obtained in those patients with a normal or mildly abnormal smal I-intestinal 
biopsy and those with a definitely abnormal biopsy (Fig. 9). The patients 
with a normal or near normal Intestinal mucosa were on average 2 lb heavier 
than/
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than the expected average weight# end the patients with an abnormal mucosa 
wetô on dVorogo 7 lb lighter than tho expected average weight. The 
difference between the two groups^  however# was not significant (t -  1.289; 
p > o .id ) .
Qastro-lntestinal Findings
Srnall -Intestinal biopsy -  The# were assigned to one of four grades *
Dissecting microscope appearances are quoted first# followed by the 
coOvantlonal microscope appearances.
Grodo 1:*^  Finger shaped v llll with varying proportions of tongue or leaf 
shaped forms (Fig. 10), In 5 patients short ridges were also seen# and In 
another patient the surface was convoluted. Histology normal (Fig# 11).
This grade was regarded os representing normal jejunal appearances#
Grade 2:- Predominantly leaf "Shaped v llll with short villous ridges# some of 
which were U«-shaped (Fig* 12)* Histologically, epithelium v/as for the most 
part normal but In sevorol area's^  although toll columnar# was lacking a 
distinct brush border and wos jnflltroted by numerous round cells. V llll 
were often slightly blunted and mWiopen. lamina propria hod on Increased 
round-cell content (Fig# 13).
Grodo 8:^ Convolutions# or convolutions and ridges, were seen In most but 
In 2 coses convolutions# ridges and looves occurred and In 2 other oases only
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ridges end leaves were present (Fig, 14). HIstologfcqlly* the features 
wore; those of partial villous ptrpphy With short# broadened “vllls’h 
degonerdted!Surface eplthell## elongated crypts of Lleberkuhn and 
Increased round-cell content dftomlna propria (Fig, 15).
Grade 4 ;* No v llll were seen. Surface was mainly flat with a fow brood 
convoluted ridges or with o mosdic pattern (Fig. 16). Histologically# the 
oppeoronqos were those of subf^ tOtol villous atrophy with cfosent or rudimentary 
"vllll"# degenerate surface epithelium# elongated crypts and Increased 
oellularlty of lomlna propria (Fig* 17),
In view of the minor nature of the cènormolltles comprising grade 2# the 
patients falling Into this grading are combined with grade 1 patients and 
designated normal when comporfson Is being made with those potlentS whose 
smal I-Intestinal mucosa was Indisputably abnormal (grades 3 and 4).
The number of patients falling Into each grade Is recorded In Table II.
In the lotal series the percentage of patients with a normal or mildly (ènormol 
mucosa (grades 1 and 2) was 47 and the percentage of patients with definite 
mucosal abnormalities (grades 8 and 4) was 53. Analysis of result# from the 
2 geogr^hlc areas reveals that the percentage of patients with definite 
mucosal abnormalities was 57% In the Western region and 44% in the North- 
Eastern region. Also of the 27 patients not on specific therapy at the time 
o f/
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of small-întesHnal biopsy învesHgatîon# 14 (52%) had definite mucosal 
abnormalities. In the 3 patients who had repeat Intestinal biopsies after 
dapsone therapy no change was noted In one patient with a grade 3 mucosa# 
In a second patient the mucosal grading changed from 4 to 3 and In a third 
from 3 to 2,
Dlsaccharldgse estimations -  The results of these estimations are recorded In 
Table III and expressed as units (micromoles of substrate hydrolysed per 
minute) per gramme wet weight of mucosa. The limits of normality used are 
those determined by Paton et al . (1966) In the some laboratory# the lower 
limits for maltose# lactase and sucrose being 13.4 units# 1.4 units and 3.5  
units respectively.
In the 4 patients with a grade 1 mucosa the dlsaccharldose concentrations 
were also normal and in the 4 patients with a grade 2 mucosa the Only 
abnormality noted was alactaslo In 1 patient.
Conversely# only 1 of the 9 patients with grades 3 and 4 mucosa had 
normal enzyme concentrations# diminished levels of all three enzymes being 
obtained In the remainder. Four of the 9 patients had qlactosla. 
lactose-"tolérance test -  The blood sugar rise was less than 25 mg/100 ml# In 
7 patients (Table IV ). Apart from one patient with a blood sugar rise of 
24 mg/100 ml and a normal lactose concentration the abnormal results were 
associated/
associated v/îtb diminished lactase activity, In only 1 of the 4 patients 
with diarrhoea and diminished lactose activity was symptoms# flatulence and 
abdominal distension# induced by the oral dose of lactose, This latter 
patient# however# was given 100 g lactose so that strict comparison cannot 
be made with those patients who received the smaller dose (50 g),
Xylose-tolerance test -  Diminished excretion was noted In 12 of the 50 
patients studied. Excretion was normal in 16 of the 25 patients with mucosal 
abnormality; and In 3 patients with diminished excretion the small-intestinal 
mucosa was normal (Table V ).
Faecal-fat excretion -  11 of the 35 patients In whom this was measured were 
found to have an increased excretion. Excretion was normal In 12of the 19 
patients with mucosal abnormality; and In 4 patients with Increased excretion 
the small-Intestinal mucosa was normal (Table V ).
Small -bowel barium meal -  Abnormalities were noted In 5 of the 12 patients 
examined and these consisted of dilatation of the jejunal loops In 2 and 
flocculation of barium In 3, In all 5 patients with an abnormal test the 
smal I-intestinal mucosa showed the features of partial or subtotal villous 
atrophy# but In the other 5 patients with an abnormal mucosa# os well as in 
2 patients with a normal mucosa# the test was unremarkable.
Haematologlcal Findings 
The haemoglobin concentration# estimated in all patients# fell below the 
accepted/
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aaCéptad lower limits of normality |n the laboratory (moles 12*5 g/TOO mis 
female# 11.5 g/100 ml) In 1Î poHent#* ' In 2 potlents the hoematologkol 
finding# Indicated o hoemolytie anaemia the patients being on 2Q0 and 150 mg 
of dapsone per doy respectively# and fn another patient o previous partial 
g#treq#my' far duodenol yloemtlon moy have contributed to; the onmrnlo.
In 8 patlontSi however# the most likely cause of onoemlo wos malabsorptions 
6 hod nbt rooelved dq^sone therapy and In 2 the dose token was low,
Details of tliese patients ore recorded In Toble VI # Anoemlo w #  diagnosed 
In 5 patients prior to attending the Skin Deportment; In 4 of these potlents 
before dermatitis herpetiformis hôd developed. A sotlsfocfory response to 
oral Iron therapy was obtained in 6 patients and In the remaining 2# Intra­
muscular vitamin and oral folio ootd were given In addition, fh all 8 
patients the {ejunnl mucosa was Anormal *
How#ll«^Jolly bodies were noted In the red cells In 3 patient# In the
51series* The oleorano© of GrWabelled autologous heat-damaged red cells 
was Investigated In one of these patient# and was found to be reduced # the 
half o le##o# time being 34 mln (normal TO -  16 mln)* and the blood 
radioactivity #  160 mln was 24-.per cent.
Biochemical Findings 
The Wum olbomin level w«l low ( /3i,8 g/lOO ml) In 4 of fbe 54 potfenti
In /
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In whom ît was measured. In 3 patients the jejuna! biopsy was normal, and 
In Only Î  patient (patient ho * 25), who had partial vllloOS atrophy and severe 
cllnioal malabsorption, could the low level (3*1 g/IOOmI) be related to the 
presence of an enteropathy (Appendix)*
The serum calcium level was determined In 47 patients and found to be low 
( <^4*5 mEq/l) In 2* In one of these the alkaline phosphatase level and 
jejunal mucosa were normal and the slight fall In serum calcium level 
(4*4 mEq/l) was probably due to a low serum albumin level (3*0 g/100 ml): 
the other was patient no* 25, already referred to In paragraph one. In whom 
the serum calcium was 2*5 mEq/l*
Serum alkaline phosphatase levels were ascertained In 50 adult patients: 
on abnormal level (^14K* -  A* units) was obtained In 3 -  patients no* 20 and 
26 In whom serum calcium levels were normal and patient no* 25 In whom the 
Sérum calcium level was low*
The serum globulin level was^3*0  g per 100 ml In 26 of the 54 patients 
examined but exceeded 4*0 g per 100 ml In only one, a patient who also 
suffered from pulmonary sarcoidosis* Conversely, the serum globulin level 
was <^ 2 g per 100 ml In 2 patients (1 *7 g per 100 ml)*
DISCUSSION
The occurrence of skin changes, particularly eczema and pigmentation,
1 /^
2 8
îs well recognised os a feature of molabsorptîon (Manson-Bahr and Willoughby, 
1930; Bennet et al , ,  1932; Kaufman md Smith, 1943; Cooke et ol, , 1953; 
Badenoch, 1960; Wells, 1962) and treatment of the intestinal disease usually 
results In marked Improvement In the skin changes (Wells, 1962; Friedman and 
Hare, 1965; Fry et ol, ,  1966), Wells (1962) emphasized that these patients 
may first present to the dermatologist# and It Is likely that this observation, 
together with the Increasing use by gastro-enterologlsts of the small-Intestinal 
biopsy capsule devised by Crosby and Kugler (1957), stimulated a reappraisal 
of the smal I-Intestine In skin diseases. Subsequently# abnormalities of the 
jejunal mucosa were described In rosacea (Watson et a l 1965), exfoliative 
dermatitis (Shuster and Merits, 1965; Shuster, 1967), psoriasis (Shuster et a l ,# 
1967), subcorneal pustular dermatosis (Van de Stack et al, ,  1970) and 
dermatitis herpetiformis (Marks et ol## 1966; Fraser et a l*, 1967; Fry et a l , , 
1967; Van Tongeren et a l , ,  1967; Bend! and Williams, 1968; Mcrks et a l . ,  
1968; ShuSter et ol, ,  1968; Berg et a l , ,  1970; Van de Staok et al, , 1970; 
Brow et ol*, 1971), The small-Intestine In pemphigoid# formerly known as 
Senile dermatitis herpetiformis, was normal (Marks and Shuster, 1969); and 
In other skin diseases only minor abnormalities were noted (Fry at al . ,  1966)* 
More recently, however, the validity of some of these findings has been 
questioned In view of further study of the characteristics of normal jejunal 
mucoid,/
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mucosa* This can conveniently be considered together with the mucosal 
classification used In the present Study#
Holmes# Hourlhan© and Booth (1961a# 1961b) described jrtio noniial 
{ejunal mucosal appearance under tW dissecting microscope os Consisting of 
finger-llko v llll or leaf-shaped y|Ml with frequently a mingling of both types 
In the some Specimen* In addition, on occasions the leaf-shaped vllll 
appeared to coalesce to form distinct ridges, a manifestation more common 
In the duodenum* Conventional histological examination alone, on the 
other hand, did not reflect these differences In macroscopic structure, merely 
sliowing 0 thin glandular layer and long slender v llll the 3-dimensional 
representation of the leaf-shaped villus and villous ridge being absent*
Thus, both macroscopic and microscopic oppearances were incorporated In 
the clarification of {ejunal mucosal appearances* This concept of normality 
was similar to that of other workers In Hio field (Scott et a l*, 1964; Rubin 
and Dobbins, 1965; Salem and Truelove, 1965; Stewart ot al *, 1967), while 
Others did not find villous rIdgeS In the {ejunum In control subjects (GIrdwood 
et al *, 1966; Burhol and Myron, 1968)* A more radical disagroomont with 
the concept of Holmes et a l*, lioweyor, was the work In Newcastle by Marks 
and Shuster (1970a) on post-mortem control subjects, In which they described 
a predominantly convoluted mucosa In 8% of jejunal biopsies* This had not 
previously/
30
previously been noted In this country although a convoluted mucosa Is a not 
uncommon finding In control subject# In several countries abroad, Including 
Southern India (Baker et a l#, 1962)# East Africa (Banwell et a l*, 1964) and 
Israel (Parkins et a l . ,  1966). Marks and Shuster suggested that the different 
mucosal appearances noted In corttrol patients by the various workers In this 
country might Simply reflect regional variation. In the some study these 
authors found that the incidence of a convoluted mucosa In dermatitis and 
psoriasis was not significantly different from their control group and so they 
withdrew their previous claims of a Structural jejunal abnormality fn dermoto- 
genlc enteropathy (Shuster and Marks, 1965; Shuster, 1967) and psoriasis 
(Shuster et ol. ,  1967)* Also, they suggested that the discrepancy In the 
jejunal biopsy findings In rosacea between the Glasgow series (Watson et a l . ,  
1965), reported as abnormal, and the London series (Marks et q l . ,  1967), 
reported oS normal, might be false due to Inadequate knowledge of normal 
jejunal mucosol appearances In the Glasgow area. In view of the above, 
therefore, the one patient In the present study with a convoluted mucosa and 
normal histology was not regarded as abnormal but placed In the grade 
representing a normal jejunal mucosa, grade 1.
The classification of the abnormal jejunal mucosal appearance by Holmes 
et o l. (1961a, 1961b) fell Into two groups. In the first, o flat mucosal surface 
devoid/
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devoid of v illi wos seen to be assocîotad with the histological q^pearonces of 
subtotal villous atrophy, and In the Second, the histological appearances of 
partial villous atrophy were represented under the dissecting microscope by 0 
series of ridges, convolutions and v/horls for which the descriptive title 
convoluted was suggested* These two categories of abnormality were noted 
In Idfopatbio steotorrhoea (adult coollao disease). They ore represented by 
grades 4 and 3 respectively In the present Study.
A number of patients In the present work hod a {e{unol biopsy qspeofanc© 
which was classified as grade 2s vHlouS ridges were present on macroscopic 
examination and minor villous and epithelial cell abnormalities on microscopic 
examination. A Similar grade Is present In the classification of several other 
workers Studying dermatitis herpetiformis (Fry et a l . ,  1967; Marks et q l ., 1968; 
Shuster et al.# 1968). These changes have also been noted In the relatives of 
coellac disease patients by MacDonald et a l. (1965), but these authors 
classified the appearance as "non-specific abnormality" as no relationship to 
gluten could be demonstrated* A similar "abnormality" ho# been described 
In pernicious anaemia (Foroozan and Trier, 1967) and rosacea (Watson ©t ol *, 
1965), and the possibility that local factors are Important In Its production 
Is suggested by the work of Townléy et al » (1964) on experimental Instillation 
of hydrochloric acid Into the jéjunum. Accordingly, In the present study, 
grade/
grade 2 mucosae were grouped; with grade 1 when comparative cssessments 
were being mode with the definitely abnormal grades 3 and 4 ,
Excluding that part of the present work previously published (Fraser et a l . ,  
1967) the changes of partial or subtotal villous atrophy of the Jejunal mucosa 
were noted In 46 of the 81 patients studied In the first 6 papers ptibllshed on 
the subject of dermatitis herpetiformis and the small-intestine (Mari<s et ql. ,  
1966; Fry et ql. ,  1967; Van TOngeren et q l . ,  1967; Bend! and Williams, 
1968; Marks et a l , ,  1968; Shuster et a l 1968). This Incidence qf 
abnormality {57%) Is very similar to the Incidence of 53% obtained in the 
present work, and further evidence against any marked regional variation In 
the prevalence of smal I-intestinal abnormalities In dermatitis herpetiformis 
was provided by the similar Incidence of abnormality found in patients In the 
North-East of Scotland (8 of 18) and the West of Scotland (24 of 42)* Such 
small variations as do exist between one area and another may simply relate 
to the small numbers of patients normally comprising a series. Another factor, 
suggested by the variation In mucosal appearance In the 3 patients wI>o had 
repeat biopsies from the some area of jejunum, is that the mucosal abnormality 
may be patchy. Indeed, Berg et a l. (1970) reported marked variation between 
two biopsies token from the some area of jejunum In one patient with dermatitis 
herpetiformis, and in another patient marked variation was noted In adjacent 
areas/
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areas of the same blopsy. More recently, Brow et o l. (1971), by; taking 
multiple biopsies of the proximal small-bowel In 22 patients with dermatitis 
herpetiformis, demonstrated that the mucosal Involvement was potohy In 5#
A similar patohy mucosol Involvement has been recorded In odult coellOa 
disease (Roy-Ghoudhury et ol #, 1967).
Disocchortdose enzyme activity correloted well with the histological 
assessment of tlie |e{unol mucosa In the patients studied (Table llt)i only 1 of 
the 9 potlants V/lth Severe mucosol change# hod normal enzyme activity, and 
in only 1 of tl|0 8 patients with q  normal mucosa was the enzyme activity reduced 
(isolated lactose deficiency). These findings are In agreement with thé published 
work in this field (Fraser et o L , 1 9^ , 1968; Shuster et ol#, 1968; Berg at ol. ,  
1970), and It is likely, as further Suggested by the beneficial effect of a gluten- 
free diet in patient no • 25, that, In most oases, reduction of enzyme activity 
is secondary to mucosal abnormality* A similar situation obtains In coellac 
disease where reduced disccchariddse enzyme activity is restored to normal on 
treatment with a gluten-free diet (Plotkin and Isselbachar, 1964; Lîfshîtz et al », 
1965)» Despite low lactase levels In dermatitis herpetiformis patlen#,. however, 
lactose Intolerance was demonstrated on only one occasion (Table (V)* This 
accords with the studies of Hammorll et al » (1965) in which asymptomatic 
lactose deficiency was described* In relation to reduced disoccharld## 
enzyme/
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enzyme concentrations and the skîn eruption. It Is of interest that Ppck-Steen 
and Niordson (1970) have reported that a milk-free diet may benefit Some 
patients with dermatitis herpetiformis. This effect, however, oppeared to bo 
related to the protein rather than the lactose content of the milk.
In general, the effect of the smal I-Intestinal abnormalities on patients with 
dermatitis herpetiformis was slight. Five patients did, however, present with 
symptoms or signs related to malAsorption prior to attending the Skin Department 
(Table I). In only 2 of these, however, was the malabsorption severe; an 
incidence of 4% which compares with thé 8% incidence in the initial Series 
referred to above. Again, the incidence of diarrhoea In the present Study 
was 19%, with 7 of the 10 patient# affected having an abnormal (ejunal mucosa; 
and this compares with a 17% incidence of diarrhoea In the initial series, 10 of 
the 12 patients affected having çn abnormal mucosa. Clearly, although most 
patients in wliom mucosal abnormalities exist do not hove diarrhoea there Is a 
good correlation between the presence of diarrhoea and an Anormal small- 
Intestinal mucosa. That the small-Intestinal abnormalities commonly precede 
the eruption of dermatitis herpetiformis is suggested by the fact that the 
symptom of diarrhoea preceded the eruption In 7 of the 10 patients witti this 
symptom, and Indeed in 2 Instances (patients no. 25 and 35) the presence of 




A# sfotçd previously, m the; mtroduçtîon to this port of the study, 
patlopls with dermatitis horpetîfprmî# ware regarded as often poorly nourished* 
No significant difference, however, was present In the variation frp0 Overage 
weight between patients with |e|pnol mucosol grades 1 and 2 and patients with 
mucosol grodo# 3 and 4 (Fig* 9), âitteugh clearly, In o relatively smdlj 
number of potleni#, on effect of #alHntestlnol obnormollty on body weight 
might be dlfflodlt to demonstrotO/Ih view of the varlA lllty of this measurement 
even In the no#ql population* fry  f t .a t* (1967) also concluded; th # . In 
general, dermatitis herpetiformis pftlontS were not underweight; although 
some patients with mucosal abnoitnolity did gain v/elght when treated with a 
gluten-free diet (Fry et o L , 1968, 1969)* It Is likely, therefore, that weight 
loss due to dfrmatltls herpetiformis enteropathy Is Infrequent and normally 
slight*
AbnormOlltfesof the two main tests of Intestinal obsoiptlon, the xylose- 
tolerance tost end the faecal-fat excretion, ware present In only a smoll 
proportion of patients, with small-intoStlnal mucosal changes; and In #me 
patients with abnormal absorption tests the Small-Intestinal mucosa w #  normal 
(Table V): the findings are slmll# to those of the Initial published series 
(Fry et q l . , 1967; Matks et ql*, 1968; Shuster et a l *, 1968). However, 
although/
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although In coellac disease the percentage of abnormal tests Is high, the 
degree of abnormality cannot be Çqrralatéd with the severity of jejunal 
mucosal changes, and appears to depend on the extent of smal I-Intestinal 
Involvement rather than Its severity Ot any one point (MacDonald at al . ,  1964; 
Stewart et al » , 1967). Brow et oL (1971) reached a similar conclusion In 
dermatitis herpetiformis by correlating faecal-fat excretion with the extent 
of small4nte#t(nal Involvement, ohd their finding of patchy mucosol 
Involvement In some patients wttfs thiS disease may explain the occasional 
presence of abnormal absorption téSts In patients with a normal jejunal mucosa 
(Table V ), For similar reasons, abnormalities detected by small-bowel barium 
meal examination were Infrequent, as were abnormalities In the serum 
biochemistry.
The Incidence of anaemia, likely to be seoondary to smal I-Intestinal 
abnormality, was also low In the present series; only 8 of the 60 patients 
being affected (Table VI). In mCSt coses oral Iron therapy produced a 
satisfactory response, and this h<# been the experience of other Investigators 
(Fry e ta l* ,  1967; Shuster et ql*, I960; Berg e ta l . ,  1970). Indeed, Fry 
et a l. (1967) reported that low serum Iron levels and Asence of Ane rnarrow 
Iron are common In dermatitis herpetiformis* In some patients low serum 
folate levels Occurred with mild mocrocytosis of the peripheral blood film 
(Table/
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(Table VS)* these latter change# have been described by many author#
(Fry e t j 4#> 1967; Marks et al * ,  ,1968; Berg et a l *, 1970; Brow ef ql * , 1971) 
and may be due to malabsorption Of food folate (Hoffbrand of ah  # 1970), 
although the chronic haemolysis produced by dapsone therapy may, by 
Increasing folate utilization, aim  contribute to the finding of low SerUm 
folate levels (Pry et a l . ,  1967) .  Severe megaloblastic anaemioi AwOver, as 
in patient no * 25,  is usually ossodlatod with a frank malabsorption state (Marks 
et o l . f  1966;,.Von Tongeren et ob.# 1967; Shuster e t a b ,  1968): foW Serum
^  ’  e t s e w e ü w w w l i  ^
B|g levels OS well os low serum.foldfo levels may be present. In général, 
however, Os would be expected frqm ti.predominantly proximal smalT^Wmtinal 
Involvement,(Brow et ql. ,  1971).,/Serum levels and the Schilling foSt for 
vitamin, g absorption are recorded OS normal in dermatitis herpetiformis (Fry 
e to b ,  1967; Shuster et a l . ,  1968; BergOtol#, 1970; Brow et ab,..\T971); 
although In .the series of Marks e| ol *. (1968) and Cream and Scott <(1970), low 
levels were npto^* Certainly, small " i^ntestinal function may not be. the only 
factor affecting:serum levels, # .Andersson et ob (1971a) hove reported 
decreased gastric secretion of intrinsic factor in dermatitis herpetiformis; 
indeed, m  a#oiotion with perntefous-anaemia has occosionolly been 
recorded (IlyoS, 1968; Wyburn-Mpfon, 1968; Gream and Scott, 1970).* 
Nevertheless, despite the possible deficiency of these various haematln.fc 
factors/
38
factors, Severe anaemia (Hb <"|0;'^/iOO ml) h  uncommon, the InoWonoe In 
the present series being 5%, and In o group of published series involving a 
total of 67 patients, the incidence',#as 4% (Proser et a l . ,  1967; Pry 0  o l. ,  
1967; Marks, 1968; Berg e tq b iÿ>197Q)* Finally, in regord to hoomOtologicol 
findings, this Study confirmed thob'Howell^jolly Adtes may be found In the red 
cells of a small percentage of patfon# with dermatitis herpetifoitnis, and that 
this Anormo!tty indlcdtos the proff net of splenic atrophy (Fry et ob # 1967).
The nature of the enteropathy In dermotltis herpetiformis and particularly 
its relationship with coelioc diseaSO has been the subject of much înyiâflgatîon. 
The significance of mild histolopifo! abnormalities in the jejunal mucosa Is 
uncertain and has been considered already, but the more severe changes of 
partial or Subtotal villous atrophy or© tdentlcql with thoso occurring In gluten- 
Induced ent^topdthy; otherwise coiled idiopathic steatorrhoea or coellac 
disease# The possible relationship to gluten ingestion was first suggested by 
Fry et a l. (19^),. and the clinicaf benefit and histological impmvement in 
the jejunal mucoso following the uSe of o gluten-free diet is now wail 
documontod (Fry et a b , 1968, 1969; Shusteretab, 1968; Marks Ot ab# 1969; 
Berg et ol », 1970; Marks and ShuStor, 1970; Van de Stock et o b , 1970; 
Weinstein et q l# 1971)* AIS0| the role of o dietary factor in the potho- 
genesis of the enteropathy is con|istont with the observation that the mucosol 
damage/
damage 1$ more severe in the proximal than In the distal smal I-Intestine 
(ShuSter et a l . ,  1968; Brow et ol*  ^ 1971), The relationship to gluten has 
been further confirmed by demonstrating the deleterious effect of gluten 
administration on a normal area of small-Intestinal mucosa (Shuster et o l. r 
1968; Weinstein et ql », 1971); on effect previously demonstrated in coelioc 
disease by Rubin et ol * (1962)»
Another aspect of the relationship A  tween the enteropathy in the two 
diseases Is seen In family studies; the presence of je{unal abnormalities In 
the relatives of patients with coellqo disease is well known (MacDonald et al . , 
1965; McCroe, 1969), and Marks et ol * (1970) Investigating 19 relatives of 
patients with dermatitis herpetiformis found je]unol abnormalities In 7 .
Indeed, patients with dermatitis herpetiformis may give a history of having 
relatives with coelioc disease (Marks et a l#, 1968; Marks et al», 1970), a 
feature noted In 2 patients In the present study. A number of other points 
of similarity between dermatitis heqsetiformis and coellac disease have been 
recorded* the lowering of serum IgM levels reported in coellac diseqSe by 
Hobbs and Hépner (1966, 1968) and Blecher et a l. (1969) Is also found In 
dermatitis herpetiformis (Fry et a l», 1967; Marks, 1968; Fraser e tq l», 1969); 
splenic atrophy described In coellac disease by McCarthy et al » (1966) has 
been recorded fay Fry et ql » (1 9 # ) in dermatitis herpetiformis, and was 
demonstrated/
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demonstrated în one patient in tA  present study; a high incidence of 
agglutinating factor to LactobaO(l|US coSoi in the sera of patients with 
coelioc disease (Cowan et a l . ,  1966) has been described in dermatitis 
herpetiformis by Fry et q l* (1967); and the occurrence of intra-abdominal 
lympAmas, previously noted in patients With coelioc disease (UpshaW and 
Pollard, 1957; Scudamore, 1961; Gough, 1962), has recently been 
described In patients with dermatitis herpetiformis (Gjone a A  Nordoy,
1970; Andersson et ol*, 1971b)*
The close relationship between ttie gut findings In dermatitis herpetiformis 
and coellac disease is further emphasized by the fact that patients have been 
diagnosed os typical examples of adult or childhood coellac disease before 
the rash of dermatitis herpetiformis had appeared (Smith, 1966; Bond! and 
Williams, 1968; Dyer and VerA v, 19#; Fraser e ta l . ,  1968; Mqyon-White, 
1969; McNeish et ol. ,  1970; Brow et ql. ,  1971 -  these reports Include 3 
patients in the present study) and by the discovery of the occasional patient 
suffering from dermatitis herpetiformis in reviews of patients with coellac 
disease attending gostro-enterology clinics (Marks and Shuster, 1971; 
Weinstein et al », 1971; Young and Pringle, 1971).
From the weight of supporting evidence, therefore, it would appear that 
the enteropathy of dermatitis heiqetiformis differs only In degree of severity 
from/
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from the condition designated obîidiwd or odult coelioc disease, and this 
difference may be artificial merely reflecting tA  fact that patients with 
overt coelioc disease form only o Smoll proportion of the Individuals with 
the smal I-intestinal abnormalities of this disease (MacDonald et o L # 1966).
However, the problem of the relationship existing between the skin end 
the small-intestine In dermatitis herpetiformis is less clear* A number Of 
different factors have been suggested over the years as forming a possible 
direct link boAeen the skin and the gut In this disease. Thus, It was 
postulated by Fry et o l, (1967) that the changes In the smol I-intestine and 
the skin might be on expression of a defect In folate metabolism, possibly 
aggravated by dcpsone therapy, but these autArs later reported that the serum 
folate levels could be restored to normal on treatment with a gluten-free diet 
(Fry e tq l *, 1968, 1969) suggesting that the low levels were secondary to 
the enteropathy rather than having a primary causative role* Also, qs noted 
in the present study, |o{unal AnormoHties were just as common in patients 
w A  hA never received dqisone therapy as In tAse who h A , and In the 3 
patients w A  had repeat jejunal biopsies after dapsone therapy, no marked 
difference in appearance was noted, There is no evidence, therefore, that 
treatment of the skin eruption with dapsone either exacerbates or improves the 
Awel abnormality, and a similar negative effect has been reported with 
sulphapyridin©/
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sulphàpyrfdine (Brow et o h , 1971)* The only serious contention now, 
in this regord, is thot gluten moy be responsible for the skin disease os 
well OS the gut abnormality. A number of authors have descrîAd Improve­
ment in the skin eruption in some patients on a gluten-free diet (Von 
Tongeren et ah , 1967; Fry et ol * ,  1968, 1969; Marks et ah , 1969;
Van de Stack et a l. # 1970; Weinstein et ol. ,  1971) but others have failed 
to note any effect (VerAv and Bdtkhan, 1967; Bend I and Williams, 1968; 
Dyer and VerAv, 1968; Fraser ©t o h , 1968; Shuster et a h , 1968; Mdyon- 
White, 1969; Berg et oh , 1970; Marks and Shuster, 1970b; McNeish ©t a h , 
1970). Indeed, several outArS have described patients. Including 2 from 
the present study (Fraser etql *, 1968; McNeish et a h , 1970), w A  first 
developed dermatitis herpetifonniS while on o gluten-free diet (BeAl and 
Williams, 1968; Moyon-White, 1969). Shuster et o l. (1968) A lieve that 
the apparent beneficial effect of a gluten-free diet in some patients can be 
explained by the fact that spontaneous fluctuations of the severity of the 
disease process In the skin occur from time to time. And so, Shuster et oh 
suggest that the relationship between the rash and the enteropathy In 
dermatitis herpetiformis Is Indirect and probably genetic in nature,
Dermotitis herpetiformis, Awever, has only occasionally been recorded in 
more than One member of a fomily (Little, 1914; Smith, 1928; Bock, 1954; 
KInmont,/
Kinniùnf, 1955; Deekem qad 1970^  Marks e t^ ..i, 1971) and ît
rnay be thaf the erupHon îs produeed by externa! faefors In the genetlwlly 
predisposed.'
SUMMARY ’ '
The status of the small intestinal mucosa In 60 patients with der#a|itls 
horpettfprmfe Is described; partial or subtotal villous atrophy was present In 
over 50% of patients* The Incidence of a frank malabsorption sfiite was only 
4% , andf although some other patients did exhibit symptoms and signs related 
to malabsorption  ^ In general the gut changes were symptomatic and 
Investigations for the presence of malabsorption often negative * Reduction 
of dlsaccharidaseooncentratlons appeared to be secondary to the mucosal 
abnormalltl# and although Iqotosa' concentrations were often loW| only one 
patient had symptoms of lactose intolerance * The enteropathy of dermatitis 
herpetiformis could not bo related to dapsone therapy and Is probably 
Identical to gluten-lnduced enteropathy (adult or childhood cooKac disease)* 
The relationship between the small intestinal abnormalities and the skin 
disease Is uncortain#
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Tim# of appearance 
of rdsh
15 M 7 ■3 Anaemia 8 months beforef
16 F 52 8 Anaemia* 8 years after





35 : M 2 4 Diarrhoea* 5 years after
54 M53 4 Anaomia 5 years after
Goeilac dtease dlagnq^d at the time of presenting featyre. 
4" rosh mild and not diagnosed ynfll 2 years later #
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(Sfopsy gr«STo) Maltose* kiçtdSc* Sucrose*
Î F 53 3 ' 2.4 0.0 0.6
2 F 53 1 21.7 1.5 5.8
3 M 33 3 4.3 0.0 0.7
4 F 58 1 17.8 3,7 4.9
5 M 67 3 10.0 1.1 2.1
6 M 49 2 15,6 2.1 4.4
7 M 69 4 3.2 1.1 0.8
8 M 33 4 4.5 0.0 1.2
9 F 20 4 1.8 0.1 , 0.4
10 F 16 . 1 21.4 3,6 5.7
11 M 14 2 15.4 0,0 4 .0
12 M 38 3 32.1 6.6 9.2
13 F 15 1 17,9 4.9 3.9
14 M 24 2 14.9 1,7 4,9
15 M 8 3 10.4 0,0 2.4
17 M 47 2 18.9 4,1 5.3
25 F 60 3 6.1 0.2 1.7
3î* 18,5 0,3 5.4
* Units of qctiyity (umol substrate hydrolysed per minute) 
per gramme of tissue wet weight (lower limits of normal -  
maltose 13.4 units, lactose 1.4 units, sucrose 3*S units).
4" Repeot Intestinal biopsy 3 years after first with patient on 
a gluten^fre# diet.
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■ 1* F 53 3 0.0 7 none
8* M 33 4 0.0 16 none
9 F 20 4 0.1 22 none
10 F 16 - 1 3,6 85 none
11 M 14 ■a 0.0 20 none
W M 38 , 3 6,6 32 none
15* M 8 s 0.0 6 '■ none
17* M 47 2 4.1 24 none




f  odits of activity (umol #uWtmte hydrolysed per minufo) 
per gramme of tis$u# wet weight*
^ ÎQO g lactose givers
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Fry et aUjt 1967; Marks et ol #, 1968; Shuster et g| »^  1968.
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Fig . 7 .  -  The Watson intestinal biopsy capsule
a
Fig. 8 .  -  The Watson capsule positioned
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45 35 25 15 5 0 5 15 25 35 45 55 45 35 25 15 5 0 5 15 25 35 45 55 65 75
Ib ABOVE OR BELOW AVERAGE
Fîg.  9 .  -  D eviation o f weights of patients w ith  grades 1 and 2 small -  
intestinal mucosa and grades 3 and 4 small -in testin a l mucosa from 
norm al. D ifferences are those between an individual and the 
average w eight for a ll individuals of the same age^ sex and height. 
The mean deviation for both groups of patients is ind icated .
Fîg.  10.  -  Dissecting microscope appearance of grade 




F ig . 11. -  Histological appearance of
grade 1 mucosa. H . and E. x 100.
»\
Fîg . 12. -  Dissecting microscope appearance of 
grade 2 mucosa showing m ainly leaf shaped 
v il l i  w ith some short villous ridges, x 10.
.'K
F ig . 13. -  Histological appearance of
grade 2 mucosa. H .  and E. x 100.
F ig . 14. -  Dissecting microscope appearance o f grade 
3 mucosa showing a convoluted pattern , x 5 0 .
F ig . 15. -  Histological appearance of
grade 3 mucosa. H .  and E. x 100.
F îg . 16. -  Dissecting microscope appearance of grade 
4 mucosa showing a com pletely fla t surface, x 5 0 .
Fig . 17. -  H istological appearance of 





After the Initial report of Màrk$, Shuister ond Wotwn (1966) on th© small- 
Intestinal abnormalities in dermatitis herpetiformis  ^ Fry et a l. (1967) In 
confirming the histological similarity of these changes to those occurring In 
adult coellao disease Sought further evidence of a relationship between the 
small-intestinal abnormalities In the two diseases. And so, the serum immuno­
globulin levels ware determined, and although the numbers studied wore small, 
a lowering of IgM occurred In one-third of patients. This accorded with the 
lowering of serum IgM levels noted previously in about one-third of patients 
with criult cooliac disease (Hobbs and Hepner, 1966),
A more detailed study of the immunoglobulin status of patients with 
dermatitis herpetiformis was undertokon and an attempt made to relate serum 
immunoglobulin levels with the presence of disease in the small-Intestîn© or 
the skin. That serum immunoglobulin levels might be related fro the skin 
eruption had been suggested by the finding of immunoglobulins and complement 
(C*3) in the dermis of patients with dennatîtîs herpetiformis (Cormane, 1967; 
Van der Meer# 1969; Cormane at o l. ,  1970) and so, fro examine this 
possibility, and, indeed, fro seek further evidence of an immune reaction in 
the skin in this disease, serum immunoglobulin and complement (C*3) levels 
were determined at different phoses of disease activity. Also, serum immuno­
globulin^
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globulin levels were onolysed in 7 other skin diseases, not associated with 
definite small-intestinal abnormalities^ tor compctrison with the results 
obtained in dermatitis herpetiformis*
PATIENTS AND METHODS
The investigation was carried out in 248 adults* The only child was a 
boy of 8 years with dermatitis herpetiformis.
The study consisted of 2 partSs^
Port Î * Subjects investigated in Glasgow*
(a) 33 patients with dermatitis herpetiformis* All these 
patients were also included In Part I of the thesis*
Two patients under treatment with a gluten-free diet 
were excluded from this part of the study •
(b) 154 patients with various other skin diseases: psoriasis 
27 cases, acne vulgaris 18, atopic eczema 15, other 
eczemas 29, rosacea 32, erythema multitorme 18, 
discoid lupus erythematosus 15*
(c) 47 control Subjects. These were healthy adults without 
skin disease: 27 medical and technical staff, 10 women 
attending a gynaecological out-patient department and 
10 healthy blood donors.
A total of 124 blood samples for immunoglobulin estimation were obtained 
from/
from th© 33 patients with dermatitis herpetiformis* This comprised a single 
blood sample In 8 patients and between 2 and 7 samples taken over o 2-12
month period in 25, The patients with other skin diseases and the control
' ' osubjects had q single blood sample onolysed* The sera were stored at -20 C 
and thawed immediately before being used*
Serum immunoglobulin estimation -  Quantitative determination of the serum 
Immunoglobulins IgG, IgA and IgM was performed by a radial immunodiffusion 
technique (Mancini et a l, ,  1964). Commercially available radial immuno­
diffusion plates were used (Hyland Immunoplates, Baxter Laborotorles Ltd., 
Norfolk, England), Specific dntlsarum to one immunoglobulin is incorporated 
In 0 uniform layer of agar on a perspex slide* The test serum Is placed in a 
small antigen well in the agar and allowed to diffuse. A ring of antigen- 
antibody precipitate forms in the agar around the well and the diameter of 
this precipitin ring reflects the concentration of immunoglobulin In the serum 
(Fahey and McKelvey, 1965). Three reference standard sera of known 
Immunoglobulin concentration were used to construct the graph of diameter 
of precipitin ring against Immunoglobulin concentration on which the immuno­
globulin concentrations of the test sera were calculated*
Part 2, Subjects investigated in Aberdeen#
(a) 19 patients wltl) dermatitis herpetiformis* 17 of these 
patients/
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patients ware indvdad in Part I of the thesis, and In the 
other 2 patients the diagnosis of dermatitis herpetîformîè was 
confirmed on sîcîil biopsy , A patient v/ith active Sjogtèn'c 
syndrome was excluded frOm this part of the study .
(b) 8 normal control subjects (medical staff).
Immunoglobulin estimations were carried out on a single blood s^iple in 
6 patients and on two blood samples, taken at an interval of at least 1 month, 
from each of the other 13 patients, Also, In 7 patients 3 blood WiîijWes were 
taken, 1 before and 2 after ©raj potassium iodide (Kl) administration $o that 
immunoglobulin levels could be estimated at different phases of disease activity: 
do|)son0 therOpy was stopped 2: ^ 6 days before the test in the 3 patients on this 
treatment.
Single blood samples from 10 dermatitis herpetiformis patients on dopsone 
therojsy were obtained to estimate Serum complement (C*3) levelsi The blood 
samples obtained during the KI test were also analysed for serum complement 
levels#
In the 8 control subjects Single blood samples were token from 4. In the 
other 4 0 further Sample was token at 24 hours; these 4 control subjects then 
swallowed 1,5 g Kl and 24 hours later a third blood sample was removed. 
Complement estimations were performed on all sera from the control subjects.
Serum/
Serum from all blood samples being used for complement analysis was 
separated Immediately and stored qt -20^C until tested*
Serum Immunoglobulm estimation -  Quantitative determination of the serum 
Immunoglobulins, IgG, IgA and IgM in this part of the study was also carried 
out by the radial immunodiffusion technique, using locally produced rabbit 
antisera * the normal range m the laboratory is IgG 700 -  1800 mg/100 ml, 
IgA 90 ” 450 mg/100 ml, and IgM 50 -  280 mg/100 ml•
Serum complement (Ç 3) estimation -  Quantitative estimation of complement 
(C*3) levels was performed with commercially available radial immunodiffusion 
plates (Hyland Immune-plates, Baxter Laboratories Ltd*, Norfolk, England)* 
The normal range is 100 -  190 mg/100 ml*
Potassium iqdIde provocation test -  An exacerbation of the disease activity 
was induced by orally administered potassium iodide (Kl) in the 7 patients with 
dermatitis herpetiformis mentioned above* A small test dose (60 mg) was given 
1 day before the full dose: this varied between 1,2 and 2 g, depending mainly 
on clinical activity at the time of the test* Each patient was started on 
dapsone therapy 24 hours after the main dose of Kl* Disease activity was 
graded in the following manner: 44*, active with bullae; 3 f, activé with 
vésiculation; 2+, moderately active with or without minimal vésiculation;
Vî-, minimally active with few lesions; 0, no active lesions present*
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RESULTS
Part 1 # Details of the 33 patients with dermatitis herpetiformis together 
with the serum immunoglobulin levels Ore given in Table V II, Where immuno­
globulins were estimated on more than one occasion the mean values are 
recorded and used for subsequent analysis  ^ The intestinal biopsy grading 
results determined in Part I of the thesis are also included in the table. 
Comparison was made between the levels of IgG, IgA and IgM in the dermatitis 
herpetiformis group and those of the control subject group. To obtain a more 
normal distribution the IgM values were converted to logarithms. The mean 
IgG level of the dermatitis herpetiformis patients at 1158 mg/100 ml v/as 
similar to the control group value of 1121 mg/100 ml (t == 0.379; P)> 0,35); 
the mean IgA value at 254 mg/100 ml was significantly greater than the control 
group mean of 188 mg/100 ml (t "  2,764; P <C0,005); and the mean IgM value 
73 mg/100 ml was significantly lower than the control group mean of 132 mg/ 
100 ml ( t - 2,534; P <0.01),
The IgA and IgM values in patients with intestinal mucosal grades 1 and 2 
were compared with the same values in patients with intestinal mucoSal grades 
3 and 4# There was no significant difference between the two groups in IgA 
values (t = 0,995; P^ 0.15) or IgM values (t -  0,701; 1^ 0.20)#
In 10 patients with dermatitis herpetiformis the initial IgA and IgM values 
were/
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were compared v/îth the second values obtained at least 1 month after storting 
dapsone therapy (Table VIII)# No dapsone effect on these immunoglobulins 
was noted; nor did any signifioant changes in IgG levels occur. Also, 
immunoglobulin levels could not be related to the duration of the skin disease 
(Table V U ).
The results of the immunoglobulin determinations in the group of other s!<ln 
diseases are shown aS the means ( Î  standard error) for the 3 classes of immuno­
globulin determined (Fig. 18, 19. and 20). The dermatitis herpetiformis group 
results were included for comparison in those figures. For each sl<in disease 
statistical comparison was made with the control group. In the discoid lupus 
erytheraotosus group serum IgA and IgM levels showed marked variation making 
analysis of results in a small number of patients somewhat unsatlsfaclory. 
Significant depression of the mean IgG level occurred In erythema multiforme; 
the mean IgA levels were significantly raised in eczema, psoriasis, rosacea 
and discoid lupus erythematosus; the mean IgM levels were significantly 
depressed In psoriasis (P <^0*00Û5).
Part 2. Immunoglobu I in studies -  The immunoglobulin values of the 19 
patients with dermatitis herpetiformis In this part of the study are recorded in 
Table IX . The IgG level was high ()> 1800 mg/100 ml) in 2 potion#. The 
IgA level wqs low (^ 9 0  mg/100 ml) in 1 patient. IgM values were low 
( <50 mg/100 m l)/
( <C50 mg/100 ml) In 5 of the 19 patients*
The results of the estimation of immunoglobulin values in dermatitis 
herpetiformis at different phases of disease activity ore recorded in Table X . 
Tho test dose of Kl had no appréciable effect on the sl<în eruption in any 
patient, but tho main dose produced an exacerbation of the disease Within 
2 hours in 5 patients and at about 10 hours in 2* The eruption exacerbated 
in sites normally affected by the disease, lesions already present flaring up 
and new ones, popular and urticarial at first and later becoming vesicular or 
bullous, appearing* Mouth lesions, however, urticarial or vesicular in type 
and later becoming hdemorrhagic, appeared in all subjects, and in 4, 
erythematous macules which later became haemorrhaglc appeared on the palms 
or soles* Side effects of the iodide administration occurred only after the 
full dose. These were noted In 6 of the 7 patients and consisted of excessive 
lochrimatton and salivation and pain In the throat and ears; pain in the region 
of the salivary glands was also noted in some patients. These are the symptoms 
of iodism and they settled without treatment in about 24 hours.
Serum complement (C*3) studied -  In the 10 patients on dapsone therapy the 
serum complement levels ranged from 64 -  150 mg/100 ml with a mean value 
of 122 mg/100 ml. This compares with a range of 9 2 -  180 mg/100 ml in 
the 8 control subjects and a mean value pf 152 mg/100 ml. Two patients in 
the/
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the dermatitis herpetiformis group had slight lowering of complement levels 
at 76 and 64 mg/100 ml respectively, but there was no significant difference 
between the dermatitis herpetiformis and control group values (t -  1.09; 
P=^0J5).
The serum complement values obtained at different phases of disease 
activity in dermatitis herpetiformis are recorded in Table X , Only small 
differences of values were noted and did not differ significantly from the daily 
variation of 8 -  15 mg/100 ml or the variation of 0 -  10 mg/100 ml after 
administration of Kl noted in the 4 control subjects.
DISCUSSION
Serum immunoglobulins have been widely studied in coeliac disease with 
some divergence of the results obtained* The most consistent finding has been 
in IgM levels where low values hove been recorded in 20 -  40% of patients 
(Hobbs and Hepner, 1966; Asquith et a l*, 1969; Blecher et a l*, 1969).
A later paper of Hobbs and Hepner (1968) recorded an even higher incidence 
of IgM deficiency, 61%, in a group of patients with untreated coeliac disease, 
and they found that treatment With a gluten^free diet frequently produced a 
return to normal serum levels. S/lfoft and Weeke (1969) also noted that a 
low mean IgM level in a group of untreated coeliac patients increased 
significantly during treatment with a gluten-free diet, but Asquith et a l. 
(1969)/
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(1969) demonstrated a sîgnîfîoqnt rise in IgM in only 2 of 10 patients with 
eoèIJac diSeme treated with this diet* Paradoxically, the local production 
of IgM in the jejunal mucosa o f-patients udth untreated coelim-dte.c^e appears 
to be actually increased as evidenced by the increased number of IgM - 
containing plasma cells (S/ltoft and Weeke, 1969; Douglas et ol* ,  1970) 
and the increase of IgM levels in the jejunal juice (Douglas ot al *, 1970), 
Consequently,, m  the lowering of IgM values has been demonstrated to be due 
to a defect in synthesis of this immunoglobulin (Brown et a l * ,  1969), a defect 
which, incidentally, may be Reversed in some patients on treatment with a 
gluten-free diet, the reduced production must occur in tissues other than the 
jejunal mucosa* Indeed, Douglas et al* (1970) have described a decreased 
number of IgM-^ontoinlng plasma colls in the bone marrov^ f in coeliac disease. 
And so, Hobbs ©t al * (1969) suggest that the IgM deficiency of coeliac disease 
is part of the depression of lymphoroticular dysfunction in this disease 
(McCarthy ot a l . ,  1966) and Is secondary to the as yet unidentified primary 
lesion *
Serum IgM findings In dermatitis herpetiformis are remarkably similar to 
those determined in cooliac disease. The mean IgM value in the present 
study was significantly less them the control mean value, and IgM levels 
below 50 m g /l00 ml v/ere noted in 13 of 33 (39%) patients in the Glasgow 
series/
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series and 5 of 19 (26%) patients in the Aberdeen series. Fry ot q # . (1967) 
and Mari<s (1968) also recorded that about one-third of dermatitis herpetiformis 
patients had IgM deficioney* This similarity In the incidence of IgM deficiency 
in dermatitis herpetiformis and coeliac disease occurs despite the fact that the 
enteropathy of the former disease Is generally mild (Part I of the the#(s) and, 
indeed, in the present work low IgM values were just os common in thqse whose 
jejunal btopSy showed o normal or mildly abnormal mucosa as in thos© with 
definite mucosal abnormalities * In the series of Fry et al * (1967) also, 2 of 
the 4 patients with IgM deficiency hod a normal or near normal jejunal biopsy. 
Brow et a l . (1971), however, hove demonstrated, by taking multiple jejunal 
biopsies, that the gut lesion in dermatitis herpetiformis may be patchy and so 
gluten sensitivity of the intestinal mucoSa cannot be excluded on a single biopsy: 
It may be that the presence of gluten sensitivity rather than the degree is the 
important factor in determining IgM deficiency. Certainly, in cpejlac disease 
Hobbs and Hopner (1968) were unable to correlate IgM deficiency with any 
parameter of malabsorption or with any qaeclfic histological appearance in the 
small4)0wel. On the other hand, only a percentage of patients with-coeliac 
disease have low IgM levels and in those v/ho have, tlie effect of a gluten-free 
diet on these levels Is, as noted obove, variable. And so, factors other than 
gluten sensitivity may be involved in the observed depression of IgM levels. 
C le a rly ,/
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Cborlyi thorofor€3|,tho înabîlîly #  relaW (gM levels to the smalhmtestfnai 
abnormolïtîos In dermatitis herpetiformis does not neeossarlly mdleafo that 
the nafore ofothe (gM ohanges W: 'dermatltls herpetiformis !$ different from 
that In cool loo disease, and the sijggestlon that In coellao disease 1§PA 
deficiency Is part of a general lymphoretlcular dysfunction (Hobbs 
1969) may aim apply In dermatitis herpetiformis where evidence ofsoch 
dysfonctfonf In the form of splenfo atrophy, has boon noted In some pationts 
(Fry et al*,  1967; Thesis, Part i)*
The possibility of IgM deflofopcy In dermatitis herpetiformis being related 
to the skin eruption must also be considered* No consistent changes In 
levels, however, were noted on control of the disease process with dçpsone 
(Table VIM) nor after the production of m  exacerbation of the disease with 
oral potassium Iodide (Table X)* On the other hand, low serum levels of 
this Immunoglobulin have been OOtod In pemphigoid (LIm and Fusoro, 1962), 
a blistering disease without an associated enteropathy (Maries and Sh^^for,
1969), and glso In pemphigus (Wdidorf and Rogentlne, 1966; Grob and 
Inderblt^on, 1967), but the deffofoncy appears to be loss marked,, a^ ' lp the 
series of Waldorf et cil , ,  only 2 of 21 patients with pemphigus had on IgM 
value below 50 mg/100 ml, and In the series of Grob and Inderbltxen only 
3 of IB patients'with pemphigus lied a mean level below 50 m^/lOO, ml: In 
neither/
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neither Series did the level of Serum IgM fall he low 40 mg/100 ml, Certainly, 
of the various sidn diseases other than dermatitis herpetiformis studied m the 
present work, low levels of IgM v/ere only noted In psoriasis (Fig* 20), a 
finding previously recorded by Krebs et al * (1968). A recent study by 
Varelxidls and Theodorldis (1971), however, has described normal IgM values 
in psoriasis. At all ©vents, unlike the frequent Increase In Serum IgA levels, 
marked diminution of serum IgM levels appears to be uncommon In skin diseases. 
No clear evidence exists, therefore, to suggest that the IgM deficiency In 
dermatitis herpetiformis Is related to the skin eruption*
In contrast to the substantial agreement on IgM levels In coélkic disease 
differing results on measurement of IgA levels have been obtained. Thus, 
Eldelman et al * (1966) and Asquith et d * (1969) noted significant increases In 
mean IgA levels In groups of patients with coollac disease whereas others 
recorded that. In general, IgA levels were normal (Hobbs and Hepner, 1968;
B lecher, 1969; S/I toft and Weèke, 1969). Nevertheless, Hobbs and Hepner 
(1968) did find high values in sonie patients; values which returned to normal 
0 0  treatment with a gluten4Vea diet in 3 of 6 patients studied # Thus, gluten 
sensitivity which q>pears to Induce tow IgM values may also Indue© high IgA 
values* Eldelman et cl * (1966) Suggested that high serum IgA levels in 
coollac disease were related to an Increase In IgA-contalnlng plasma calls 
In /
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în the Ssï!0 !l'"'întosfîncîl mucosa, but nwo recent studies have foiled to show a 
significant increase In the numbers of these cells (S/Itoft and Week©, 1969;
Doug Ids et al * ,  1970). An Indfodse of thdse cells might have been expected 
to occur where serum IgA levels dre high as the plasma cells of the întestînà! 
mucosa contribute significantly to the pool of circulating lgA;(Vaerm^n and 
MerémanS, 1970). The situation in coelîac disease is further complicated by 
the association in'some patients the intestinal lésion of coeliac dispose with 
severe isolated IgA deficiency (Crabbe md Heremans, 1967). Indeed, study 
of two large series of patients with cool lac disease has Indicated that IgA 
deficiency has an Incidence of about 1 in 50 (Asquith èt q l *,  1969; Beale 
et g | . ,  1971). These low levels of IgA are associated with a marked diminution 
in the numbers of IgA'^containing plomaa cells in the jejunal mucosa (Crobbe 
and Heremans# 1966), a situation which also obtains in IgA deficiency 
unassociated with gluten enteropathy (Eidelman et al », 1966; Ridelman and 
Davis, 1968; Douglas et a l 1970). It would oppear, therefore, fhot IgA 
levels in patients with coelidc disease may be increased, normal or decreased 
and so, in view of the wide scatter of results, comparison with the findings in 
dermatitis herpetiformis is difficult.
In dermatitis herpetiformis the mean IgA level was significantly Increased 
compared with the mean of the control group (Fig. 19) although only 1 of 52 
patients/
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patients had an IgA level above 45Ô mg/100 ml, Marks (1968), however,
*  I
found the mean IgA level normal, and Fiy et q|, (1967), in his series of 12 
patients, noted only 1 patient with a high IgA level (450 mg/100 ml). In 
relation to low IgA levels, 2 of the 52 patients had a clearly significant 
IgA deficiency (63 and 42 mg/100 ml) an Incidence of isolated IgA deficiency 
similar to that recorded by Hobbs and Hepner (1968) in their study of 75 
patients with coeliac disease, and very much higher than the 1 in 500 
incidence reported for the normal population (Bachmann, 1963; HObbs, 1968), 
IgA levels in dermatitis herpetiformis could not be correlated with the 
intestinal mucosal histology but in coeliac disease too serum IgA levels could 
not be related to the IgA “-containing plasma cell population of the {ejunal 
mucosa (%^ltoft and Weeke, 1969; Douglas et al >, 1970). Recently, it has 
been demonstrated that despite normal or high serum levels of IgA in coeliac 
disease a qualitative defect in this immunoglobulin occurs (Beale et a l . ,
1971 ). The finding of a similar qualitative defect in dermatitis herpetiformis 
would further increase the likelihood of the IgA changes in this disease being 
related to the enteropathy rather than the skin eruption. Such an investigation, 
however, has not os yet been reported.
Previous work has noted the presence of high IgA levels in several skin 
diseases (lim and Fusaro, 1962; Varelzidls et a l . ,  1966; Grob and 
Inderbitzen,/
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Inderbitzen, 1967) and the frequent occurrence of this abnormality is confirmed 
in the present study where high mean IgA levels were present in 4 of the 7 
other skin diseases studied (Fig , 19), In psoriasis, clearing of the skin eruption 
produced a return to normal of high IgA values (Varelzidls and Theodorîdîs,
1971) but no such alteration was noted, in the present work, on control of the 
skin eruption of dermatitis herpetiformis with dopsone (Table VIII). Also, the 
serum IgA levels did not alter significantly during an exacerbation of the disease 
process produced by Kl (Table X). However, in view of the frequency of high 
IgA levels in skin diseases it may well be that the presence of the skin eruption 
In dermatitis herpetiformis does confributo, to some extent, to the high IgA 
levels.
The results obtained on investigation of serum IgG levels In coeliac disease 
are even more variable than for the other Immunoglobulins, Thus, Hobbs and 
Hepner (1968) and S/I toft and Weeke (1969) stated that In general IgG levels 
were normal, Blecher et a l. (1969) found that a considerable proportion of 
patients had raised IgG levels and Asquith ©t a l. (1969) reported the mean IgG 
level in a group of coeliac patients was significantly lower than the mean 
level in a control §roup. S/I toft and Weeke (1969) while noting an increase 
in IgG containing plasma cells in the je|unal mucosa of patients with coeliac 
disease could not correlate Serum levels with this increase. At all events, 
no/
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no significant difference was noted between the mean IgG level in the 
dermatitis herpetiformis patients and the controls (Fig, 18). Abnormal results 
within the series were few: the IgG was over 1800 mg/100 ml In 5 patients 
and the IgG was less than 700 mg/100 ml In 2 patients, Similar findings 
have been reported by Fry et cil » (1967) and Marks (1968). Alterations 
in serum IgG levels do not appear to bo a common feature in diseases of the 
skin as thoy were noted in only 1, erythema multiforme, of the 7 other skin 
diseases studied (Fig. 18).
The possibility of an Immunological reaction occurring in the skin In 
dermatitis herpetiformis has been suggested by the finding of immunoglobulins 
and complement In the dermal papillae in this disease (Van der Meer, 1969; 
Germane ot a l . , 1970; Chorzelskî et a l . ,  1971; Cormane and Giannatti, 
1971; Holubar ©t a l . ,  1971). Immunoglobulin-complement complexes occur 
in the dcin (Kolsboek and Cormano, 1964; Ten Hove-Opbroek, 1966) and 
renal glomeruli (lachmann ©t a| », 1962; Paronetio and Koffler, 1965;
Koffler et gl . ,  1967) in systemic lupus erythematosus, and In the dermal 
blood vessels of patients with allergic vasculitis (Stringa et a l , ,  1966; 
Copeman, 1970), and a fall of Serum complement levels during exacerbations 
of these diseases provides evidence of an active immunological reaction 
(Elliott and Mathieson, 1953; Wedgowood and Janeway, 1953; Morse et al «, 
1962;/
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1962; Townes et gl,. , 1963; Schur and Sondsoo, 1968; McDuffie, 1970), 
Consequently, pqrtjcularly as allergic vasculitis affects the skin to approximately 
the same extent as active dermatitis herpetiformis, a fall In serum complement 
levels could have been expected in dermatitis herpetiformis If a similar 
immunological reaction occurred. No significant alterations in the serum 
levels of complement were obtained at different phases of skin disease activity 
(Table X ), However, the main Immunoglobulin detected in the skin In 
dermatitis herpetiformis is IgA and as this Is only complement-binding when 
attached to secretory piece (Adinolfl et a l . ,  1966) the complement present in 
the skin may not be involved in the main immunological reaction. It may be, 
indeed, that the quantity of complement present in the skin Is insufficient to 
affect serum levels, a situation which presumably obtains in pemphigoid where 
normal serum complement levels are reported (Katz, Inderbitzen and Holprln,
1970) despite the presence of Immunoglobu I In -comp lement complexes In the 
skin (Chorzelski and Cormane, 1968) and basement-membrane zone antibodies 
in the serum (Beufner et a l , ,  1965; Chorzelski et a l , ,  1966; Jordan et a l , ,  
1967; Chorzelski et a l . ,  1968), Serum immunoglobulin levels, like the 
complement levels, did not change significantly during the Kl investigation 
(Table X) and although this does not exclude an antibody response In dermatitis 
herpetiformis (the antibody response would require to be massive to be 
detectable/
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detectable On estimation of gross immunoglobulin levels) these findings do not, 
provide any further evidence in favour of an immune reaction in tho skin in 
this disease
Thus^  the immunoglobulin changes in dermatitis herpetiformis seem more 
likely to be associated with the enteropathy than related to the skin lesions  ^
but the cause of these abnormalities is still uncertain,
SUMMARY
Serum immunoglobulins, IgG, IgA and IgM were determined in 52 patients 
with dermatitis herpetiformis: 33 patients comprised the Glasgow series, and 
19 the Aberdeen series* Mean immunoglobulin levels of patients in the Glasgow 
series were compared with mean levels obtained in a control series: the mean 
IgG level was not significantly different from the control mean; the mean IgA 
level was significantly raised; and the mean IgM level significantly lowered. 
Results for individual patients revealed an abnormally high IgA level in only 
1 patient, and an abnormally low level in 1 patient from each series* Similarly, 
the results for each series were comparable in IgM levels, low levels occurring 
in 39% of patients in the Glasgow series, and 26% of patients in the Aberdeen 
series* These Immunoglobulin changes are similar to those occurring in coeliac 
disease* Immunoglobulin values, however, could not be correlated with the 
histological appearances of the small-intestinal mucosa* Also, Immunoglobulin 
levels/
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levels were unafFected by dapsone therapy and could not;be relOtOd to the 
duration or activity of the skin dl#ase. Estimation of serum immunoglobulin 
and complement (C*3) levels at diffèrent phases of disease activity did not 
provide any further evidence for;an Immunological basis to the skin eruption# 
Serum Immunoglobulin determlndfîônSi In the 7 other skin diseases studied, 
revealed th^t on Increase In th# moan IgA level occurred commonly whereas a 
definite lowering of mean IgM level was noted only in psoriasis# It was 
concluded that the serum Immunoglobulin abnormalities in dermatitis 
heip^tiformis cannot be clearly related to the presence of disease in the 
small-intestine or the skin and may be part of a general lymphoreticular 
dysfunction In this disease.
TABLE Vfl -  Serum tmmunqglobuHn levels and Other Petoîls în 83 Patien# 













# # m g l 
/(do ml)
. .... ........"" !!".
obulîos*
IgG teA IgM
1 F 53 3 1 1032 83 36
2 ' F 58 20 1 1416 267 81
3 F 16 1 1 1204 212 57
4 F 15 12 1 918 63 179
5 F 58 3 1 880 848 61
6 . M 62 ,  2& 1 525 158 17
7 M 54 ' 4 1 1995 300 125
8 M 14 2 2 896 111 42
9 M 24 1 • 2 939 , 331 47
10 M 47 2 2 816 274 76
11 M 24 7 2 780 420 60
12 M 26 i 2 850 180 20
13 F 72 8 2 1004 207 33
14 M 20 5 2 1006 107
13 M 60 1" 2 1148 800 53
16 F 53 1 3 920 ■ 134 48
P M 33 4^ 3 1420 278 35
18 M 67 12 3 1201 334 107
19 M 38 à 3 1995 380 66
20 M 8 2& 3 1122 102 38
21 F 63 3 3 1027 229 37
22 M 29 Yrs 3 646 180 30
23 M 54 17 3 1882 411 22
24 M 50 15 3 1494 259 71
25 M 56 3 3 1737 3^ *1 156
26 M 37 è 3 1532 403 59
27 M 29 1^ 3 1000 166 110
28 F 58 42 3 928 82 147
29 F 39 15 3 769 95 107
30 F 26 2% 3 1S85 295 186
31 M 69 15 4 1476 540 119
32 A4 33 1 i 4 924 370 23
33 F 20 2& 4 1128 287 62
Normal range: IgG 700 -  1800 mg/100 ml; IgA 90 450 mg/100 ml; 
IgM 50-. 280 mg/100 ml #
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B A B A
3 F 16 196 182 13 53
4 F 15 89 56 208 240
5 F 58 345 398 56 70
9 M 24 446 402 53 50
11 M 24 420 360 60 50
13 F 72 180 200 35 19
21 F 63 360 300 38 36
23 M 54 360 398 20 17
28 F 58 70 85 100 224
33 F 20 195 360 14 60
* Normal range; IgA 90 -  450 mg/100 ml; IgM 50 -  280 mg/100 ml # 
B -  before dqpsone therapy A =; after dopaene therapy
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1 F 49 9 t 1440 156 116
2 M 6 2 4 1 1420 174 16
3 F 42 11 1 1068 292 76
4 F 57 2 1 1340 172 144
5 M 59 12 1 1590 426 22
6 M 54 è 1 1670 220 98
7 F 42 4 g 1 1600 128 76
8 M 37 1 1 1000 125 82
9 M 62 1 2 1000 100 136
10 M 45 3 3 1200 156 44
11 F 48 5 3 1960 124 188
12 F 34 è ' 3 1636 138 64
13 M 20 1 4 800 42 92
14 M 59 1 4 1710 156 35
15 F 14 2 4 1838 190 121
16 M 20 i 4 950 106 36
17 M 33 i 4 1600 228 58
18 F 62 4 950 180 130
19 M 69 7 1268 96 60
*  Normal range; IgG 700 ■* 1800 mg/100 ml; IgA 90 -  450 mg/100 ml; 
IgM 50 -280  mg/100 ml.
/ ô
TABLE X Serum ImmunoglobuUns and Complement (C*3) Levels at Different 









(mg/100 ml) C'3 
(mg/100 ml'IgG IgA IgM
10 a 3h- none 1120 128 34 80
b- 4h* none 1360 208 45 86
c 2f dopsone 1200 156 44 86
5 a 3»- none 1300 434 16 110
bo 4i* none 1250 452 20 115
c 2i- dopsone 1340 492 24 105
3 a 0 none 1000 368 92 83
b 3+ none 940 368 92 80
d 2+ dopsone 908 360 88 86
14 (1 2+ none 1420 184 41 130
b 3f none 1280 180 39 150
d 2+ dopsone 1180 176 36 150
4 a 2f none 1240 160 168 120
b 3f none 1040 120 128 130
d 2*^ dopsone 1280 156 160 120
6 a 2+ none 1660 296 128 130
b 3^ " none 1660 320 140 145
e 0 dopsone 1520 328 120 145
15 a 1+ none 1660 236 146 105
b 3+ none 1580 232 136 105
e 0 dopsone 1380 208 132 115
1
Timing of samples; a -  before pO|a$sium Iodide ’(Kl); b * 24 hours after K I; c -  7 days
before Kl; c «14 days before Kl; d -  3 days after Kl; e -  7 days 
after KL










1000 * * I i A
500
Significant difference from  control group (P < 0 .0 1 )
F ig . 18. -  Levels o f IgG (m g /1 00 m l) in control 
subjects and patients w ith ^arious skin diseases. 
Results expressed as mean -  standard error.
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*  Significant difference from control group (P < 0 . 01)
F ig . 19. -  Levels o f IgA (m g/100 ml) in control 
subjects and patients w ith^ario us  skin diseases. 
Results expressed as mean -  standard error.







'‘Significant difference from control group (P < 0 . 01)
F ig . 2 0 , “ Levels of IgM  (m g/100 ml) in control 
subjects and patients w ith^ario us  skin diseases. 
Results expressed as mean -  standard error.






Although dermotîtîs horpotîformîs hod been described by Duhring in Î884 
no serious wggestlon of an association with small-Intestinal disease had been 
put forward before the recent work using the small-Intestinal biopsy capsule 
(Marks et o L # 1966; Fraser et dl * ^  l967; Fry et a l>, 1967; Van Tongeren 
et oL , 1967; Bend I and Wil I lom$| 1968; Marks et o L # 1968); tlie failure 
to recognise the association was due to the Infrequent occurrence of clinical 
malabsorption even when relatively large numbers of patients were studied 
(Smith# 1966). During the previous ports of this study (Parts I and II) several 
patients with dermatitis herpetiformis were noted to have concomitant auto­
immune disease# particularly thyroid disease, Review of the literature also 
revealed the occasional association of dermatitis herpetiformis with thyro­
toxicosis (Du Costel# 1912; Werther# 1923; Hansen# 1937; Rattner et a l*# 
1930; Smith# 1966) and# more recently# pernicious anaemia (Ilyas# 1968; 
Wyburn-Mason# 1968).
And so# to ascertain the possibility of a significant association between 
dermatitis herpetiformis and autoimmune disorders a study was undertWcen to 
determine the Incidence of serum antibodies of organ specific and non-organ 
specific types and# further, to Seek to relate any abnormalities found with 
the presence of disease In the Small-Intestine (Part I) or the previously noted 
changes/
changes in the immunoglobulin levels (Port II).
PATIENTS AND METHODS
The Investigation for the presence of thyroid and gastric autoontîbodles 
was undertaken In 42 adult patlen# (males# 22; females# 29) and a boy of 8 
years. These comprised 33 patients Included In Port I of the thesis# and 10 
patients not previously Involved In the work# The diagnosis of dermatitis 
herpetiformis In these latter patients hod been determined on histological 
grounds In 9 and on clinical grounds alone In 1 # 28 of the patients 
from the Glasgow area and 15 from the Aberdeen area* The control series# 
matched for age and sex# consisted of 41 patients with skin diseases and 2 
normal persons# Overt putative autoimmune diseases# Including thyroid 
disease and pernicious anaemia# were excluded from both series: the patients 
excluded from the test series were 4 patients with a history of thyroid disease 
(thyrotoxicosis# 3; Hashlmoto'S disease# 1) and 1 patient with Sjogren’s 
syndrome.
Serum samples wore obtained from patients and controls and stored at -20^0 
until used* All samples were tested at the same time to avoid Inaccuracies 
caused by variation In the sensitivity of the test procedures which mcy occur 
at different times. The method of Fultliorpe et el , (1961)# Involving the 
agglutination of tanned red cells coated with human thyrogbbulln# was used 
to /
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to test for thyrogfobulîn anSlbodîos: the fluorescent ontîbôdy teçhnîquo of
Coons and Kaplan (1950) was uSod to look for thyroid microsomal and gastric
parietal cell Ontlbody* In those patients with gastric parietal cell antibody
examination for the presence Of Intrinsic factor antibody was undartoken by
the method of Arctaman and CbcnOrln (1963) In which the dblllty of this
60antibody to block the uptake of Co-vltqmln ^7 ®®rum In the presence 
of nomiat gastric juice Is u tille d .
Investigation for the presence of antlnucleor factor was undertokou hi 51 
adult patients (males#'29; famoles# 22) -  45 patients who had been studied 
In Fort t of the thesis# and 6 otiier patients with dermatitis herpetiformis from 
the Aberdeen area; the diagnosis having been made On clinical and histological 
grounds# Patients with putative autoimmune diseases wore excluded as before. 
Examination for the presence of dntlnuclear factor In the serum w 0 performed 
using the Immunofluorèscent technique (Beck# 1961). Investigation of a 
control series was not carried out*
The results of small-Intestinal biopsy and serum Immunoglobulin assays 
carried out In Parts I and II of the thesis respectively were used for analysis of 
results In this part of the study.
RESULTS
Thyroid aufogntlbodies (Table X l) -  Thyroid microsomal antibody was present 
In 9 patients (males# 5; females# 4) with dermatitis herpetiformis and In 1 
control/
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control subjeot; X « 5 .^ , ç l P  <C0,02. Th/roglobulln antibody In titres 
1 1ranging from gg^occurred In. 6 patients (all female) end did not occur in
the control subjecls. As 2 patfonb with the latter antibody did not hove
.thyroid microsomal antibody th#Overall Incidence of thyroid antibody was 11
2In the dermatitis herpetiformis group and 1 In the control subject group; X ^ 
7.8# d .f^ 1 # P -0.005*
GastrtO oufocmtlbodles (Table X I) -  Gastrtc parietal cell antibody was present 
In 10 patients (males# 7; females# 3) with dermatitis herpetiformis and In 4 
control subjects (females# 3; male# 1). This difference Is not significant. 
Intrinsic focfor antibody was not present In any of the 10 potlerits wlfh gastric 
parietal cell antibody. Five # t^he 10 patients with gastric parietal, cell 
antibody also had thyroid microsomal antibody.
Antlnueleqr factor -  S of the ST;;pqtlentS with dermatitis herpetiformis hod . 
antlnuclear factor In the serum.
Relationship of thym Id and gastric cufoaitH^odles to the small «Intestinal 
mucosa ood #rum Immunoglobulin levels « 5 of 13 patients wWi oufeantlbody 
In whom Intestinal biopsy hod been performW# showed severe muçoicl 
abnormalItfos; on Incidence of abnormality similar to that obtained In the 
whole series (Port I).
Immunoglobulin levels were available (Part II) for 9 patients with Serum 
aufoantibody/
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aufoantibody and 1Î patien# without serum aufoantibody, In 2 pationts 
(Î from each group) serum IgA levels were <\90 mg/TOD ml# and as IgA 
defielenoy k  known to bo'assooîated with m  Increased Incidence of auto­
immune disease (Hobbs# 1968; Gossldy et al * # 1969; Ammann and Hong# 
1970)# these patients were excluded from the statistical analysis. The 
patients In both groups formedport of the Glasgow series of Immunoglobulin 
estlmqtlOM thus allowing valid pomporlson* No significant difference was 
present between IgA levels In the 2 groups (t -  0.601; ?)> 0*25)# but a 
significant difference was present between the serum IgM levels in the 2 
groups (Pig. 21 )s the mean IgM value In 8 patients with cwtoantibpdy In 
the serum was 44 mg/100 ml# and the mean IgM value In 10 patNnSf without 
autoantlWdy In the serum was 98 mg/100 ml (t -  3.467; P <^0.0025).
DjSeUSSION
Little attention has been paid in the past to disease processes occurring 
In association with dermatitis herpetiformis# and the references made to 
concomitant thyrotoxicosis mainly Sought to Indicate that thyroid hyperfunction 
could aggravate the skin eruption. ThuS# Hansen (1937) In discussi# the 
previously noted association of the two diseases (Pu Castel# 1912; Werther# 
1925) and reporting a patient of hi# own with dermatitis herpetiformk and 
thyrotoxloosis# stated that the giving of thyroid extract to another dermatitis 
herpetiformis/
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herpatifomiSs patfent.-.wjth normal thyroîd''lunctîon .caused the d<în eruption 
to exacerbate. Similarly# Rqth#r et cil *' (1950)stressed tlie deleterious 
effect of thyroid overactlvlfy When recording that oral potassium Iodide# 
given preopemtivoly: to a patient with dermatitis herpetiformis and thyro- 
toxicosis# paradoxically produced an Immediate Improvement In die skin 
eruption. Smith (1966), however# on noting that In 2 of 3 patients: With 
both diseases the skin eruption Settled after subtotal thyroidectomy# suggested 
that the eruption In these cases was a cutaneous manifestation of thyroid 
overactlvity# analogous or mén related to the generalised pruritus which 
may occur In thyrotoxicosis, r#hêr than true dermatitis herpetiformis. On 
the other hand# treatment of the thyrotoxicosis present in the 3 patients 
excluded from this part of the Sfody did not produce clearing of the W<(n 
eruption# and'this was also tru#-$f the patient recorded by Andersson e tjc j. 
(1971a). It IS more likely# thwfore# that the Impmvement noted In Some 
patients op treatment of the thyroid dl^rder Is nort-^^eclflc# and not 
Indicative, of a basic difference. .|'n the skin disease process.'
In seeking further to determh# the status of thyrotoxicosis In patî.énts - 
with dermatitis herpetiformis, advantage was taken of the fact that thyro^ 
toxicosis Is regarded as one of the autoimmune thyroid disorders# the 
histological changes of auto-lmmuo© thyroiditis (lymphocyte Infiltration and 
Askanqxy/,
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Askondxy cell change) being found In most thyrotoxic glands (Gall and Coombs# 
1968). These glandular changes correlate well with the presence of thyroid 
microsomal antibody In the seru# (Goudle et al ,# 1959) and# Indeed# this 
antibody wqs found In the sera of 65% of thyrotoxic patients In one Series 
(Anderson et al •# 1964). And SO# the finding of an Increased Incidence of 
this ontlbody In dermatitis herpetiformis patients with normal thymid function 
(Table X I) would suggest that thero Is on Increased Incidence of subcllnlcal 
thyroiditis In these patients# and that Study of a large series of patients might 
reveqi q signlfleant association with clinical autoimmune thyroid disease.
The occurrence of dermatitis herpetiformis and thyrotoxicosis In the some 
patient# therefore# may have more Significance than previously thought.
pernicious anaemia# another member of the autoimmune group of diseases# 
has also been reported In ossoclotfon with dermatitis herpetiformis olthough 
on only q few occasions (Ilyas# 1968; Wyburn-Moson# 1968; Groom end 
Scott# 1970). Atrophic changes In the gastric mucosa constitute the 
pathological abnormality of perhtotous anaemia and gastric parietal cell 
antibody Is present In the serum Of about 90% of patients with this disease 
(Taylor et q |. # 1962). Convemely# the presence of this antibody In the 
serum correlates well with the occurrence In the stomach of vorying degrees 
of gastritis (Adams et o l.# 1964). And so# the Increased Incidence of gastric 
parietal/
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parietal cell antibody In the serum of patients with dermatitis herpetiformis 
(Table X I) would suggest on IncrOc^ed Incidence of gastritis In these patients. 
Intrinsic fqcfor antibody studies were negative and# therefore# did not provide 
evidence for the presence of latent pernicious anaemia In those patients with 
gastric parietal cell antibody; but as the former antibody is found In the 
serum of only about 60% of pOtlents with the overt disease (Ardeman and 
Chanorln# 1963)# foese negative findings are not conclusive. Indeed# a 
low secretion of acid and Intrinsic factor has been reported In dermatitis 
herpetiformis (Andersson et a l.# 1971a)# a finding consistent with the presence 
of gastritis Inferred from the present autoantibody study# and low serum 
levels have been noted by some authors (Marks et a l. # 1968; Cream and Scott#
1970). And so# although the common lowering of serum folate levels in 
dermatitis herpetiformis# and the demonstrated malabsorption of food folate 
(Hoffbrand et q l.# 1970)# would Indicate that folic acid deficiency Is the 
main factor In producing megaloblastic anaemia In this disease# the findings 
discussed above would suggest that a significant association may also exist 
with pernicious anaemia.
The finding of an Increased Incidence of organ-specific qutoantibodles 
In dermatitis herpetiformis again raises the question# previously discussed In 
Part II# of the skin disease process Itself being of an Immunological nature. 
Certainly#/
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Certaînl/i 1$ lîfHe to $ugg©$t thaj^  dermafrJtîs herpetîformîs îs an 
autoimmune disease: the histological reaction in the skin consists of on 
acute inflammatory cell infiltrate rather than the lymphocytic Infiltrate 
of organ “Specific autoimmune disease; the male sex preponderance (Wyatt 
et q l,* 1971) contrasts with the female preponderance of organ^specific 
autoimmune disease; the rare familial occurrence of dermatitis herpetiformis 
(Marks et o l. ,  1971) contrasts with the well known familial incidence of 
organHipecific autoimmune disease; and, whereas serum autoantibodlos 
against the affected organ are usually present in patients with organ^specîfîc 
autoimmune disease  ^ circulating Skin antibodies are not present In dermatitis 
herpetiformis (Chorzelski et a l», 1967; Jordan et a l.# 1967). However, 
patients with autoimmune disease c^pear to have an increased liability to 
react to various antigens, Thus, In thyroid disease Blizzard et al » (1959) 
have reported an Increased incidence of allergic reactions, particularly 
against penicillin, and in the relatives of patients with pernicious anaemia  ^
Whittingham and Ungar (1969) hove described an increased prevalence of 
allergic diseases. Conversely, Serafini et q l, (1965) noted that patients 
with type I hypersensitivity diseases (asthma and allergic rhinopathy) had 
an increased incidence of thyroid and gastric autoantibodies in the serum * 
And so, the results of this part of the investigation could be regarded 0$ 
further/
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further evidence to suggest that the immunoglobulins and complement found 
in the skin in dermatitis herpetiformis (Van der Meer, 1969; Cormane et a l, ,  
1970; Chorzelski et a l. , 1971; Cormane and G ionnetti, 1971; Holubar et a!. ,
1971) are Involved in an immunological reaction.
The possible relationship of organ-^specific autoantlbodles to the disease 
process in the small “Intestine must also be considered, since Seah et a I # (1971) 
reported that these autoantibodies were increased not only In dermatitis 
herpetiformis but also In adult coeliac disease. However, no correlation 
could be established between serum autoantibody and {ejunal cfonormaltty in 
dermatitis herpetiformis patients; the proportion of patients with mucosal 
change In the group with autoantibody was similar to the incidence of 
mucosal abnormality in the series as a whole.
The possibility of serum autoantibodies in dermatitis herpetiformis being 
related to immunoglobulin abnormalities was suggested by the reported 
observations of an increased Incidence of autoimmune disease in serum IgA 
deficiency (Hobbs, 1968; Cassidy at al . ,  1969; Ammann and Hong, 1970) 
and by the report of Lancaster “Smith and Strickland (1971) in which they 
correlated the presence of serum autoantibodies in a group of patients with 
adult coeliac disease with serum IgM deficiency. Consequently, a 
correlation was sought between the presence of serum autoantibodies in 
dermatitis/
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dermqtttîâ herpetiformis and the immunoglobulin obnormalities noted in 
this disease (Port II), Only Î pOtient with serum outoantibody hod a low 
serum IgA level, but serum IgM levels were significantly lower In the group 
of patients with outoantibody than in the group of patients without auto- 
antibody in the serum. The incrOaSed activity of cellular immune mechanisms 
in IgA deficiency which are thought to produce the increased incidence of 
autoimmune phenomena (Hobbs, 1968) may also be operative where IgM 
deficiency occurs, particularly if a qualitative defect of IgA, as has been 
reported In coeliac disease (Beale et a l.# 1971), 1$ also present in dermatitis 
herpetiformis.
The non^rgan -specIfic autoimmune diseases hove not been reported in 
association with dermatitis herpetiformis, but Seah et o l, (1971) suggested 
that 0 more general immunological disturbance than occurs in orgon -^Specific 
autoimmune disease may be present in this condition in view of their finding 
of an increased Incidence of antinuclear factor and the presence of anti- 
reticuiln antibody. Surprisingly, although Seah and his colleagues found 
an even higher incidence of antî-retîculîn antibody in adult coeliac disease 
than in dermatitis herpetiformis, no increase in the incidence of antinuclear 
factor was noted In the former disease. Similarly, lancaster-Smîth and 
Strickland (1971) did not discover antinuclear factor in any of their 23 
patients/
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patients with adult coeliac disease. The incidence of antinuclear factor 
in dermatitis herpetiformis in the present work (6%) was very much smaller 
than the 35% incidence noted by Seah et al * and was, in fact, similaf to 
the 4% Incidence which they noted in their control group,
The description of antibodies reacting against the basement membrane 
zone of tho {efunol mucosa in Some patients with dermatitis herpetiformis 
(Dick et al 4, 1969) also raises the possibility of an Immunological upSet 
involving a number of different tissues being present in this disease, but, 
while a similar antibody has been described in a group of patients with coeliac 
disease and IgA deficiency (Ammann and Hong, 1971), Holubar et ql * (1971) 
were unable to confirm the findings of Dick and her colleagues in dermatitis 
herpetiformis#
In conclusion, therefore, the occasional reports of the occurrence of 
orgqn-Specifio autoimmune disease in patients with dermatitis herpetiformis, 
together with the increased incidence of thyroid and gastric autoantibodies, 
may indicate the presence of a defect of immune tolerance in this disease; 
the reports suggesting that this defect Is of a general nature are, however, 
largely unconfirmed.
SUMMARY
The incidence of thyroid and gastric autoantibodies in the sera of 43 
patients/
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patients with dorsnatllfe herpetiformis was deWrmlned end compared with o 
control group matched for age dnd sox# Eleven patients with demiOtltls 
herpetiformis hod thyroid outoantibody In the serum (thyroid microsomal 
antibody, 9; thyroglobulln antibody, 6) compared with 1. control Subfect 
with thyroid microsomal antibody# This difference Is statistically significant. 
Ten patients with dermatitis herpetiformis had gastric parietal cell antibody 
In the serum compared with 4 control subjects/ This difference does not 
reach Statistical significance# ■ Intrtmla factor antibody was not present In 
any of the 10 patients with goStfîç antibody# The presence of thyroid or 
gastric autoantibody could not be related to small-Intestinal biopsy flndmgs, 
but a significant relationship wos noted with low serum IgM levels# The 
incidence of antinuclear factor w # determined in 51 patients with dermatitis 
herpetiformis and was found in the serum of only 3 patients# It was concluded 
that while these findings suggest thot o relationship between dermatitis 
herpetiformis and organ-specific autoimmune disease may indeed exist, 
they do not {Support the suggestion of a more general upset in immune tolerance 
in this diseo#,
Addendum;
The diagnosis of dermatitis herpetiformis was., subsequently found to be 
erroneous l.n 2 patients Included,.In this part of the study; the boy of 8 years
who/
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whovWOS qcqepW Into thojnvestîgotîon on alîntoal grounds qlono (he had 
previously attended'the Skin Deportment ai a cose of darmotîtîsjierpftîformîs 
over 0 period of 5 yeors) was later found to be non-reactive: to oral potassium 
Iodide, and biopsy of an earlyjfosfon showed a folliculitis.reaction histologically; 
and a woman of 59 years diagnosod on clinical and histological grounds later 
developed pemphigoid. Autoantlbody was not present In the serum Of either of 
these patiente and so their excjuifon from the series would. If anything. Increase 
the significance of the results.
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TABLE XI -  Incidence ôf Thyroid and <3qstrte AutoanfibodlêS in Patients
with Dermatitis Herpetiformis ancTin Control Subioots.
D!agno$f$ (and number) of pdtîents
Number of patients with Dermafftis herpetiformis (43) Controls (43)
Thyroid microsomal 
antibody 9 1
Thyrog lobu I in antibody 6 0
Either type of thyroid 
antibody 11 1









e •  
e
WITH ANTIBODY WITHOUT ANTIBODY
F ig . 21 . “ Serum IgM  levels in patients 
w ith and w ithout antithyroid or a n t i-  
gastric antibodies in the serum.
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GENERAL DISCUSSION
The oxlsfonoe of an assocîaflèn betwoon dermqtîHs herpeHformte ànd 
small-!nfo$Hnal disease was not suspected from the literature on this disease: 
the investigation of Marks et qt # (1966) was part of a survey of the #ucture 
and function of the smalHntestine In various sitin diseases; and the present 
investigation was begun to test the hypothesis that the variation in the dose 
of dapsono necessary to control the rash was duo to a drug-induced enteropathy 
with consequent malabsorption of the drug. The survey has demonstrated, 
however, that the incidence of smell-Intestinal abnormality in dermatitis 
herpetiformis is similar whether treatment with dopsono has been given or not; 
and It Is unlikely that absorption Of the drug Is significantly altered by the 
presence of ^a!l4x>weI abnormality (Alexander et a l. ,  1970).
The failure to recognise the association of small-Intestinal disease with 
dermatitis herpetiformis before thé use of the small-intestinal biopsy capsule 
is not surprising, hov/ever, In view of the Infrequency of a severe malabsoq t^lon 
State (on Incidence of 4% In P#t I). The relative absence of symptoms and 
signs of malabsorption, and the frequency with which malabsorption tests were 
normal even In patients with severe mucosal changes, has been the experience 
of all Investigators in this field. Marked depression of disaccharidose enzyme 
concentrations was associated with these mucosal changes but, although lactose 
concentrations/
concentrations were often low, lactose intolerance was noted in only one 
patient# The disparity between, the severity of the histological d>normalîtîes 
and the mildness and infrequency of Symptomatology is likely to he due to 
these abnormalities affecting only a limited extent of the small-intestine.
The enteropathy of dermatitis herpetiformis is generally accepted fo bo 
gluten-induced and; although this aspect was not ^eclfioolly studied, patients 
no# 25 and 35 (Appendix) were diagnosed in medical units as cases of adult 
and childhood coeliac disease respectively, and treated successfully with a 
gluten-free diet, before they developed the skin eruption of dermatitis 
herpetiformis* Other evidence indicative of the similarity between the 
enteropathy of dermatitis herpetiformis and gluten-induced enteropathy or 
coeliac disease was also obtained; in Part I splenic atrophy was demonstrated 
in one patient; a similar serum Immunoglobulin pattern to that occurring In 
coeliac disease v/as described In Port II; and, in Part III, an increosed 
incidence of serum autoantibodies was noted, a feature which has been recorded 
in coeliac disease by Seah et al * (1971) and Lancaster-Smith and Strickland 
(1971).
In view of the experience of having two patients who developed dermatitis 
herpetiformis while under treatment with a gluten-free diet, this study did not 
examine the possibility that the skin eruption as well as the small-intestinal 
abnormality could be due to gluten sensitivity, a possibility which has now 
been/
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been rejected by most authors# Instcacl,;serum immunoglobulin levels were 
determined and an attempt made to relate the abnormalities found fo the 
presence of disease in the small ^ intestine or the skin.
The immunoglobulin abnormalities noted in dermatitis herpetiformis were 
similar fo those which have been reported in coeliac disease; the mean IgA 
level was Increased and the mean IgM level decreased. No direct relationship 
was evident, however, between high IgA or low IgM levels and the presence 
of mial I -Intestinal abnormality. This does not necessarily mean that the 
dy sgammag lobu 11 nciemia of dermatitis herpetiformis is basically different from 
that of coeliac disease, as a single Intestinal biopsy In dermatitis herpetiformis 
does not exclude patchy mucosal Involvement and, also, although gluten 
sensitivity does appear fo influence immunoglobulin levels in coolkic disease, 
a more basic defect than gluten sensitivity is likely fo exist In the latter disease 
In view of the variable effect of gluten withdrawal on these levels. Further 
comparison, therefore, of the lymphoretlcylar dysfunction of dermatitis 
herpetiformis and coeliac disease must await a clearer understanding of the 
nature of the disturbance in both diseases.
The reports describing Immunoglobulins, mainly IgA, and complement In 
the dermal papillae of patients with dermatitis herpetiformis (Van der Meer,
1969; Cormane et a I . ,  1970; Chorzelski et o L , 1971; Cormane and G îannettî, 
1971;/
92
1971; Holubar et al , , 1971) have suggested thqt;the skin eruption may be due 
to an Immunological reaction. The finding of on Increased Incidence of thyroid 
and gastric autoantlbodles (Port III) would lend some support to this suggestion, 
since patients with autoimmune disease appear more likely to suffer from other 
types of Immunological reaction (Blizzard et ql . , 1959). However, Immuno­
globulin levels could not be related to the duration or activity of the skin 
eruption and serum complement levels did not alter significantly during different 
phases of skin disease activity (Port II). These latter findings do not, of course, 
exclude the occurrence of m  Immune reaction In the skin In dermatitis 
herpetiformis but do further emphasize the possibility that If Such a reaction 
does occur It Is of a minor nature #
The specificity of the Immunoglobulin changes In dermatitis herpetiformis 
was Investigated by determining Immunoglobulin levels In a variety of other 
skin diseases# The frequency with which IgA levels were raised Indicated 
that high IgA levels In skin diseases must be Interpreted with caution, but as 
lowering of IgM ,levels to the extent seen In dermatitis herpetiformis Only 
occurred In psoriasis, the pattern of Immunoglobulin change In dermatitis 
herpetiformis Is likely to represent a q^eclfle dysgammaglobullnaemla.
Tho significance of these Immunoglobulin changes was further emphasized 
In Part III when an Increased Incidence of thyroid and gastric autoantlbodles 
was/
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was found in dormotlHs herpotiformis; -those autoouHbodîos being roloîod not 
to the presence of small-Intestinal disease but to low serum IgM levels*
Thus, If a significant association does exist between dermatitis herpetiformis 
and organ specific autoimmune disease, and It was to test this byt^ othesls 
that Port III of the study was undertaken, then the defect of immune tolerance 
would appear to be related, not to the skin eruption or the small-înfoMînaî 
abnomialliy, but to the lymphordtîoular dysfunction responsible forthO low IgM 
values. Thé absence of an increased Incidence of antinuclear factor, on the 
other hand, would weigh against the defect In Immune tolerance In dermatitis 
herpetiformis being of a goneral nature, although evidence In favour of such 
a defect has been reported by Seah pt oL (1971).
This investigation, therefore, has Indicated that In dermatitis herpetiformis 
there 1$, In addition to a skin eruption, tho frequent presence of small- 
intestinal abnormalities, and eVldénco of an Immunological upset both In 
relation to serum Immunoglobullrt levels and Immune tolerance# Thé relation­
ship between these three aspecff of the disease -  dermatologlcal, Intestinal and 
Immunological ** Is at present uhknown, and the benefit to the patient with 
dermatitis. hcTpetlformls of the aWUmulated knowledge Is relatively sinoll, 
Nevertheless, dermatitis herpetlforrnls Is now far removed from being simply an 
eruption/
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eruption on 0i© skin, and it should prove possible in the foreseeable future 
to correlate the three aspects of the djseose fo the further benefit of the 
patient and the speciality#
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CONCLUSIONS
1 * The changes of partial or subtotal villous atrophy of the small-intestine were 
present in over 50% of patients with dermatitis herpetiformis.
2. Symptoms and signs suggesting malabsorption were usually mild or absent and 
laboratory Investigations for malabsorption were frequently negative.
3* The incidence of severe clinical malabsorption was 4%.
4 . Deficiency of disaccharidase enzyme concentrations, particularly lactose, 
occurred in association with the small-intestinal mucosal abnormalities, but 
lactose intolerance was noted In only one patient,
5. Serum immunoglobulin studies showed an increase in the mean IgA level and 
a decrease in the mean IgM level in dermatitis herpetiformis. These 
abnormalities could not be related to small-intestinal disease or the duration 
or activity of the skin disease,
6. No further evidence in support of an immune reaction in the skin being 
responsible for the rash of dermatitis herpetiformis was obtained: immuno­
globulin and complement levels did not alter significantly during different 
phases of dcin disease activity*
7. Estimation of serum immunoglobulin levels in 7 other skin diseases, not 
associated with small-intestinal abnormality, revealed that whereas serum 
IgA levels were frequently raised, lowering of serum IgM levels to the extent 
seen/
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seen în dermatîHs herpetiformis occurred only in psorlosis. These results 
indicoted that the Immunoglobulin obnormalities obtained In dermotltis 
herpetiformis were unlikely fo be a non-specific effect of the d i^n eruption. 
8, An increased incidence of thyroid and gastric autoantlbodles in dermatitis 
herpetiformis supported the proposition that an association exists between 
this disease and organ-specific autoimmune disease.
9# The presence of outoantibody did not correlate with small-Intestinal
abnormalities but a significant correlation was present with low serum IgM 
levels. This suggested that a defect In Immune tolerance secondary to 
dySgommoglobulInaemio was present In dermatitis herpetiformis.
10* The incidence of antinuclear factor In the serum of patients with dermatitis 
herpetiformis was low, and there was, therefore, no evidence of a general 
upset in immune tolerance , 
n  * The evidence from all three parts of the study supported the contention that 
the enteropathy of dermatitis herpetiformis is identical to that of coeliac 
disease; but no direct relationship was noted between the small-intestinal 
and immunological abnormalities, and the disease process in die skin.
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Cltnfccil histpry and findings -  thfe patient aged S7 years, was admitted to 
the medico! wards in October 1?6S with o 16 month history of weight loss and 
a 7 month history of flatulence ond diorrhoeq. On oxomination she hod q low 
grade pyrexia, evidence of weight loss, q red smooth tongue, angular stomatitis 
and marl<ed pqimar erythema* 0tood pressure was ^^m m  Hg# Abdomen was 
rather fu ll.
Investigations -  Haemoglobin 9 g/IQO ml; P .C .V. 29%; M X .H .G . 31%; 
E.S.R# (Wostergren) 60 mm in 1 h; fllm-anîsooytosîs, target cells, macrocytosis, 
hypersegmented polymorphs. Morrow examination -  megaloblastic change, 
stafnoble iron present. Serum vitamin uug/ml. Schilling test -
0.5% dose excreted in urine in 24 hours. Figlu test positive. Serum iron 
40 ug/100 ml, total Iron-binding capacity 204 ug/lOD ml, saturation 20%.
Serum sodium 140 mEq/l; potassium 3.3 mEq/l; chloride 99 mEq/l; blood 
urea 23 mg/lOO ml. Albumin 3*1 g/100 ml; globulin 2.8 g/100 ml*
Bilirubin 0.9 mg/100 ml; thymol turbidity 1.4 Mac logon units; calcium 
2.5 mEq/l; inorganic phosphotU 2.3 m g/l00 ml; alkaline phosphate© 19 King- 
Armstrong units/100 ml. Tubular reabSorption of phosphate -  97%. X-roy of 
spine -  osteoporosis. Urine xylose excretion after 3 g dose -  0.77 g in 5 
hours./
hours* Small-bowel x^ray -  fbqpulqtion of bqrlum in the small Intestine* 
Jejunal biopsy -  ridged and convoluted mucosa under dissecting microscope; 
low broad Irregular v illi, long crypts, degenerate epithelial cells and plasma 
cell Infiltrate In the lamina propria under light microscope * Results of 
dtsaccharidoso assay or© in Table X II * The diagnosis of adult coeliqc disease 
was made and she was treated initially with vitamin folic acid, intra­
muscular Iron, Parentrovlte, vitamin 0  and calcium and gluten-free diet*
One year later her weight hod increased by 42 lb and treatment was 
continued with a gluten-free diet, folia acid Ï0  mg b.d#, ferrous Sulphate 
0.2 0 t.i.d *  and vitamin 1,000 ug monthly*
In February, 1968, the patient noticed an itching, blistering eruption 
affecting mainly the scalp, extensor surfaces of the elbows, abdomen and 
back of the knees. In April, 1968, skin biopsy of an érythématouS papule 
showed the typical papillary microabscesses of dermatitis herpetîformîSf The 
patient's only other complaint at this time was of occasional flatulence and 
abdominal distension after meals# Clinical examination was negative. 
Investigations -  Haemoglobin 14.1 g/100 ml; P .C .V . 42%; M .C .H .C* 34%; 
E.S.R* (Westèrgren) 15 mm In 1 h; film normal. Albumin 4.3 g/100 ml; 
globulin 2.5 g/100 ml. Thymol turbidity 2.2 Maclagan units; bilirubin 
0*7 mg/100 ml . Calcium 4*7 mEq/l; inorganic phosphate 2.7 mg/100 ml; 
alkaline/
127
alkaline phosphatase 12 King-Armstrong unlts/lOO ml# lactose tolerance test 
maximum blood sugar rise after 100 g lactose was 14 mg/100 ml. Abdominal 
pain and flatulence occurred during the test, JefunOl biopsy again showed 
partial villous atrophy. The infiltrate of Inflammatory cells In the lamina 
propria was imre marked than In the previous biopsy. Dtsaccharidose results 
are shown In fable X II, The patient's flatulence was thought to be due to 
lactose intolerance and she was advised to adopt a gluten-free, lactose-free 
diet. The skin eruption showed a good response to dopson© therapy, 
Treofmant with a gluten-free diet in this patient resulted in relief of 
diarrhoea and a gain in weight of 42 lb. There was, however, no Significant 
change in the structural jejunal mucosal abnormality and although maltose and 
sucrose activity reverted to normal, lactose activity remained low and was 
responsible for the lactose Intolerdnce,
Patient No, 35
Clinical history and findings -  This patient was admitted to the paediatric 
medicol ward In July 1962 ot the age of 2 years with a history of having bouts 
of loose pole stools since the age of 6 months: mixed feeding had begun at the 
age of 2 months. At the time of investigation his height was on the 25th 
centtle and his weight on the 20th cent!le.
Investigations -  Haemoglobin 9*6 g/100 ml; film -  hypochromic. Serum iron 
1 6u g /l0 0 m l,/
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16 uq/100 ml * Fot balance test with a 40 g fat ln[tqk© -  86% absorption .
Small4)0wel x-ray examination r  malabsorption pattern,. Je|unal biopsy -  
subtotal villous atrophy * X- r^oy examination of spine -  osteoporosis.
A diagnosis of coellac disease was made and treatment with a gluten-free 
diet instituted. This produced resolution of symptoms and growth acceleration 
until both height and weight reached the 75th cent!le . For a period of 6 months 
in 1965 a normal diet was resumed against medical advice, and this resulted in 
a weight loss of 1 kg. A gluton- f^roe diet was restarted, weight gain resulted, 
and thereafter the diet was strictly maintained,
In January 1968, over 5 years after starting treatment with a gluten-free 
diet, he developed an itching eruption on extensor surfaces of olbov/S and knees, 
buttocks, sWulders and face. The lesions were erythematous and urticarial In 
appearance but failed to reqx>nd to oral antihistamines. H© was then admitted 
to the ward for investigation.
Investigations -  Kl test -  oral ingestion of 350 mg Kl induced a marked 
exacerbation of the rash, and skin biopsy sliowed the histological features of 
dermatitis herpetiformis. Haemoglobin and full blood count normal * Serum 
proteins and immunoglobulins normal * Xylose excretion -  42% in 5 hours. 
Faecal fat excretion (ward diet) 3,8 g/day. Jejunal biopsy -  normal*
The/
129
The coelictc disease was In clinical, biochemical and histological 
remission On a gluten-free diet when the eruption of dermatitis herpetiformis 
first appeared* Dopsone therq^y was given, and the eruption settled.
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TABLE X II -  Effect of Gluten-Free Diet on Weight and Intestinal Mucosa In
Patient No. 25.
Before gluten-free diet After gluten-free diet
Weight 105 lb (47.6 kg) 147 (66,7 kg)




* Units of actlvify (umol substrate hydrolysed per minute) 
per gramme or tissue wet weight.
